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Abstract
Central-line-associated bloodstream infections (CLABSIs) occur during the insertion or
change of the dressing of the central venous catheter (CVC) and are reportable healthcare-associated infections at the state and the national level. The purpose of this
systematic review of the literature was to evaluate and synthesize available evidence to
establish the effectiveness of using an adhesive transparent chlorohexidine gluconate
(CHG) Tegaderm™ gel dressing for CVC in the prevention of CLABSIs. The logic
model was used as a framework to guide the review of the literature to establish how an
intervention that is not currently practiced can contribute to CVC prevention of infection.
The practice question focused on gathering evidence to support the effects of CHG
Tegaderm™ gel central-line dressing compared with the Biopatch® dressing. A total of
373 articles were retrieved and 16 met the inclusion for review and were graded
according to the Melnyk and Fineout-Overholt hierarchy level of evidence and evidence
synthesis broken down into the reduction of CLABSI, the cost-effectiveness and ease of
use of the CHG Tegaderm™ gel. Findings from the systematic review supported the use
of CHG gel dressing as a CLABSI preventative measure. The findings from the project
support positive social change by reducing CLABSI and associated illnesses and saving
the increased cost, mortality, and morbidity associated with CLABSIs.
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Section 1: Nature of the Project
Introduction
A central line-associated bloodstream infection (CLABSI) occurs when germs
enter the bloodstream through an inserted catheter in the large vein in the neck, chest, or
groin to give medications or fluids or collect blood for medical tests. They are inserted in
the major veins that are close to the heart and can remain in the place for weeks or
months. Because of the proximity to the heart, they a have high likelihood of causing an
infection known as a CLASBI. The infection of the central line can occur during the
insertion of the central line or while caring for the central line site during the check or
change of the dressing. CLABSI results in deaths of thousands of patients each year and
billions of dollars are added to the United States health care cost burden. CLABSIs are
deemed to be preventable nosocomial infections if guidelines, tools, and protocols are
adhered to (Healthcare-Associated Infections, 2010). CLABSIs results in thousands of
deaths each year resulting in the loss of lives and increase in the billions of dollars spent.
To decrease the rate of CLABSIs, nurses and health care team need to address and have a
quality improvement intervention that will be practical and efficient. Therefore, having
an intervention that is tailored to the reduction of CLABSI will be beneficial in the fight
of the deadly disease known as CLABSIs (Williamson, Neusbaum, & Messing, 2017).
Nature of the Doctoral Project
The practice problem involved the systematic review of the effectiveness of using
the adhesive transparent chlorohexidine gluconate Tegaderm™ gel for adults older than
18 years admitted to the critical care unit with the central venous catheter. In my project,

2
I searched published literature for credible evidence to validate the use of adhesive
transparent chlorohexidine gluconate Tegaderm™ gel for central venous catheter
dressings as an evidence-based treatment modality to decrease the CLASBI rate. My
project involved surveying the current literature to identify the empirical evidence
available of how the use of the adhesive transparent chlorohexidine gluconate
Tegaderm™ is superior for reducing the CLABSIs and make recommendations to the
local acute hospital. I conducted a systematic literature review to validate the research
question to recommend the findings of the evidence-based practice from published
literature from credible databases and Google Scholar.
Positive Social Change
The recommendations of the Tegaderm™ CHG can have a positive impact on
social change in the society and the healthcare at large. Patients are less likely to survive
when they develop CLABSI, especially if there is an already a disease that has weakened
the immune system. Having a dressing that will prevent central line infection will
promote the well-being of the patients and decreases chances of mortality, hence saving
lives. On the economic perspective, the Tegaderm™ CHG has economic benefits not
only to the facility but also to the health care at large. When patients develop, an infection
related to the central line catheter, the financial toll is passed to the hospital and the
taxpayers. Reducing the amount of money that is spent on health-care-associated
infections can be channeled to other social services that will improve citizens’ lives, thus
contributing to the positive social change that aligns with Walden’s vision for positive
social change (Walden 2020, n.d).
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Problem Statement
Local Nursing Practice Problem
Central venous catheters are widely used in intensive care units and acute care to
administer drugs or fluids. The populations in adult intensive care units are critically ill
and susceptible to infection. When catheters are introduced into the patients’ bodies, they
become an easy port of bacterial entry if proper care is not taken. The use of Biopatch®
with central line dressing has been widely used for years, but the CLABSIs rates are still
high. There is a new intervention that has emerged using Tegaderm™ with CHG gel,
which is transparent and adhesively secures the central line site and allows the clinicians
to view the site. The dressing acts as a barrier against external contamination, and the gel
pad has an antiseptic agent. The water-vapor-permeable CHG-impregnated gel pad is
incorporated onto the adhesive side of a transparent polyurethane dressing, and the CHGimpregnated gel pad is applied directly over the insertion site at the time of catheter
insertion or during follow up site care. The gel rapidly softens at skin temperatures and
flows about the catheter, providing intimate contact of the CHG-impregnated surface
with the entire insertion site. The gel also absorbs up to eight times its weight in fluid,
preventing accumulation of moisture on the site. The integrated dressing tightly secures
the catheter, preventing any positioning movement that can facilitate entry of
microorganism into the insertion tract. (Maki, Stahl, Jacobson, & Pyrek, 2008). Patients
who have central venous catheters or arterial line catheters are critically ill and are
susceptible to developing CLABSIs due to microorganisms that can be formed during the
insertion, during use, dressing change, or spread from another source. The use of CHG-
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impregnated dressing placed during the time of CVC insertion and dressing changes
ensures the dressing to release the chlorhexidine onto the skin for a 10-day period.
Local Relevance
The decrease in CLABSIs is essential for nursing practice especially with a
facility that is aiming for magnet designation and to decrease the mortality and morbidity
associated with CLABSI. Money that spent on treating CLABSI can be used to buy state
of the art equipment that facilitates a favorable environment for nursing staff.
Tegaderm™ CHG is easier to use and reduces the rate of infection. The local facility is
targeting to transition from the standard CVC dressing with Biopatch® to the
Tegaderm™ CHG gel if enough evidence exists to convince hospital leadership that the
latter is better than the current dressing. Also, the goal of the local critical care unit is to
have decreased numbers of CLABSIs per 1,000 central line days. The nursing goal is to
provide a nurturing and healing environment that restores the well-being of the patients.
The local hospital applies the 2011 Centers for Disease Control (CDC) guidelines with an
aim in preventing the CLABSI. After the central line insertion or during the dressing
change, a chlorhexidine impregnated sponge (Biopatch®) is applied at the site of
insertion and covered with a sterile, transparent, semipermeable dressing per the 2011
CDC guidelines (CDC, n.d.). Despite adhering to the CDC guidelines on the care of
central venous catheter, the facility continues to have high numbers of CLABSIs.
Significance to Nursing Practice
Decreasing the rate of infections is a paramount goal that each nurse and the
whole nursing profession aim to increase the safety and health outcome. The doctoral
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systematic review project yielded evidence-based data that can be implemented by the
local critical care unit or other units in the local hospital and in the field of nursing
practice. The systematic review was used to establish the validity of this proposed
treatment modality to decrease CLASBIs. The completed extensive systematic review of
the literature yielded the highest level of evidence to support the practice, thus build more
trust and buy-in of the use of CHG Tegaderm™ in CLABSI prevention (Jenks et al.,
2016). Nurses are at the forefront in implementing evidence-based practice in the
improvement of patients care outcome and decrease the cost of health care. In this
essence, the use of a dressing that is tailored in the reduction of CLABSI can have a
significant influence in patients’ safety and health care costs, and it can add knowledge to
the body of nursing on the best intervention based on the available highest level of
evidence to support the proposed treatment modality. By conducting this systematic
review, the evidence obtained that is highly ranked on the hierarchy pyramid of evidence
is clear that the use of evidence-based interventions is a pillar in the growth of nursing.
Therefore, the evidence obtained clearly and strongly supports the proposed treatment
modality (Stango, Runyan, Stern, Macri, & Vacca, 2014).
Purpose Statement

CLABSIs are one of the lists of diagnosis that are deemed by the Centers for
Medicare and Medicaid Services’ (CMS) as the list of nonpayable preventable hospitalacquired conditions. CLABSIs cases are costly with a case being estimated to cost
$25,000 to $32,000. The cost burden is left on the healthcare organization to bear.
Healthcare facilities continue to invest time and resources to reduce CLABSIs, and yet it
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continues to be a challenge (Strickler, Gupta, Doucette, & Kohli-Seth, 2018).
Approximately 250, 000 bloodstream infections occur annually with most of them related
to intravascular devices. The CLABSI rates in the United States intensive care units are
estimated to be 0.8 per 1000 of central line days (Jackson & Davies, 2015). The local
critical care unit has current CLABSI rate of 0.962 and the whole hospital has a CLABSI
rate of 1.232 for the current fiscal year starting October 1, 2017, to September 30, 2018.
The critical care leadership in the local hospital has identified the following needs:
1. To decrease the numbers of CLABSIs per 1000 central line days.
2. To achieve the target goal 0.641 per fiscal year.
Despite the guidelines for central line insertion and central line maintenance,
CLABSI rates remain a challenge in health care. Being one of the nonpayable hospitalacquired conditions, it is important for the hospitals to manage to eliminate the cases of
CLABSIs if possible, to save dollars and lives. My purpose in this systematic review was
to evaluate and synthesize the available evidence-based research on the use of adhesive
transparent CHG Tegaderm™ in the reduction of CLABSIs in the central venous
catheter. The anticipated outcome of conducting this systematic review was to yield
evidence that will support the need of implementing the proposed treatment intervention
with an aim in decreasing the rates of CLASBIs and to fill the gap in nursing practice on
the best method or effective method to reduce CLABSIs cases.
Gap in Practice
The reduction of CLABSI is an area that many hospitals are still struggling to
control. The local hospital still has struggles with CLABSIs with most time doing worse
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than the national average. The critical care leadership team anticipates a decrease in the
rate of CLABSIs with the introduction of CHG Tegaderm™ instead of the traditional
Biopatch® dressing based on the available evidence to prove that the use of CHG gel
dressing is superiors and economical to the use of standard dressing with Biopatch® as
currently being used if approved by the administration. With increasing need to provide
the highest quality and minimize the rate of central line infections, the gap in nursing on
the reduction of CLABSIs still exists on the best highest quality method that can be used
to decrease or have zero chances of CLABSIs. My purpose in this systematic review of
the literature was to evaluate why the use of transparent IV dressing with CHG gel is
essential to reduce the infection compared to the standard CVC dressing with Biopatch®
during the insertion and dressing changes. The results of the systematic review will be
essential to the facility and the nursing practice to contribute how the deadly disease can
be prevented and how nurses can contribute to the quality improvement process of a
hospital to improve patients’ outcome. The results create wealth of knowledge in nursing
practice through synthesizing of broad evidence for quick reference to back the
implementation and provision of care guided by the current and strongest evidence from
credibly published literature.
Practice-Focused Question
The practice-focused question in my study was: “Does the use of adhesive
transparent chlorohexidine gluconate gel Tegaderm™ for adults above 18 years of age
admitted to acute and critical care unit with the central venous catheter decrease the
central line- CLABSIs rate?”
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Addressing the Gap in Practice
By addressing this systematic review, the results of the review addressed the gap
in the need of finding the best solution for decreasing the rate of CLABSI. The use of
transparent intravenous (IV) dressing with CHG gel pad is considered superior to the
standard transparent dressing with Biopatch® because it reduces the rate of infections,
allows easy access to the insertion site, and is deemed to be easy to use by nursing staff.
The evidence obtained has proven that for the facility to achieve the target of decreasing
the rate of CLABSIs, the CHG gel dressing should be implemented together with other
central line care bundles. Facilities that were using Biopatch® before conducting the
studies of how effective the use of CHG gel is compared to the standard dressing or the
use of Biopatch® revealed that the use of CHG gel can and will decrease the rate of
CLABSIs compared with the other dressings. For instance, in a study that was done in a
critical care unit for nine months of the use of CHG Tegaderm™ dressing, 70 of 81
subjects interviewed indicated that they prefer the dressing compared to the standard
dressing (Karpanen et al., 2016). The staff also considered the dressing more
straightforward to use, and 77 of the respondents in the survey recommended for future
use compared to the standard dressing they were using before (Karpanen et al., 2016).
The CDC and the CDC’s Healthcare Infection Control Practices Advisory Committee
(HICPAC) recently approved and recommended the use of Chlorhexidine-impregnated
dressings for the central venous catheters because of their barrier to prevent bacterial
penetration to catheter site preventing CLABSIs. The recommendation is based on the
systematic review of the literature, quality of evidence, and infection rate. The dressing
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should be for only adults 18 years and older. It should be chlorhexidine-impregnated
dressings with a U.S. Food and Drug Administration (FDA)-cleared label as is indicated
to reduce CLABSIs and recommended to protect the insertion site (Public Relations
Newswire, 2017).
Nature of the Doctoral Project
Sources of Evidence and Approach
The systematic review involved reviewing evidence after a clear formulated
clinical question was developed. The question helped to identify, select and appraise
relevant published literature to collect data from the reviewed studies. The process that I
used was a systematic approach to avoid any biases, random errors, arbitrariness, and
personal opinions. The systematic review process involved setting clear objectives that
had predefined eligibility criteria for the study after identifying a methodology for the
study. The eligibility criteria were set to aid in the systematic search of the literature. I
followed the systematic review steps as noted in the Walden DNP systematic review
manual (Walden University Manual for Systematic Review, 2017). I used the Walden
University manual for systematic review and used Walden University library and Google
Scholar while conducting the systematic review of the literature for the above DNP
project. I obtained researched articles from the sources such as Cochrane Database of
Systematic Reviews (CDSR), National Library of Medicine (NLM), PubMed Health,
Biomed Central, Cumulative Index to Nursing & Allied Health Literature (CINAHL),
Joanna Briggs Institute EBP Database, ProQuest Nursing and Allied Health Source
database, and Google Scholar. The search words used included central venous catheter,
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Tegaderm™ CHG, standard intravenous dressing, adult critical care, bloodstream
infection, chlorhexidine gel dressing, and catheter-related bloodstream infection
(CRBSI).
The inclusion criteria included only articles published within ten years and
published in the English language, randomized controlled trials, and nonrandomized
controlled clinical trials. All other research methods were excluded. The demographic
characteristics of the population that qualified for inclusion included adults older than 18
years, adults admitted in acute and intensive care units, nurses taking care of the adult
critically ill patients. The exclusion criteria were patients with already existing
bloodstream infections and patients younger than 18 years.
Approach to Organize and Analyze the Evidence
I organized the evidence obtained after searching the literature in the Microsoft
Word matrix table and created an evidence summary table from each selected study. I
used the level of evidence using Melnyk-Fineouts’ hierarchy pyramid (Melnyke &
Fineout-Overholt, 2011) to grade the evidence obtained. I used the preferred reporting
item for systematic reviews and meta-analysis (PRISMA) flowchart diagram to illustrate
the procedure to select the articles (McInnes et al., 2018). The evidence that I obtained
during the search of the literature was categorized based on the strength of evidence of
the study. I further analyzed the evidence obtained based on the strongest level of
evidence to answer the practice-focused question and explain why the use of CHG
Tegaderm™ is superior in the prevention of CLABSI compared to the existing traditional
Biopatch® dressing. The evidence helped to answer the clinical question and fill the gap
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in the practice of controlling the high incidence rates of central line infections and
provide a clear evidenced-based practice of using the adhesive CHG gel Tegaderm™ in
the reduction of CLABSIs based on supporting evidence from the literature.
Significance
Stakeholders
The stakeholders that will be affected by addressing the aforementioned problem
include but not limited to the patients, nurses, physicians, midlevel providers, infection
control practitioner, hospital administrators. External stakeholders such as the CDC,
government agencies and payers, health care organizations among others will be affected
by the reduction of CLABSIs. Understanding the role and contribution of each
stakeholder is an important part. To ensure full support of a project that involves different
stakeholder, it essential to involve a multidisciplinary team when introducing new
practice. For instance, CLABSIs being a nonrefundable event by Medicare, it is essential
to involve the administration or management to have a buy-in in the change of practice if
the rates of CLABSIs are going to be decreased or brought to zero cases. The physicians
and the advanced practitioners are the ones who insert the central line. Therefore,
involving them and teaching how the change of the current practice will impact their
work and have the competence or knowledge of the new dressing when inserting the
central line will increase the buy-in and ensure support of the new practice. Nurses are
the one who change the dressing after it is inserted. Teaching them and providing facts
and evidence-based prove that the dressing is superior and easy to use is important. All
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stakeholders who will impact the new change should be involved directly to ensure the
success of the new practice.
Contribution of the Doctoral Project to Nursing Practice
Doctoral prepared nurses contribute to the growth and improvement of patients’
care by designing, implementing, and evaluating therapeutic interventions based on
nursing science as is evidenced by the essentials of doctoral education for advanced
nursing practice Essential III: Clinical Scholarship and Analytical Methods for EvidenceBased Practice and Essential VIII: Advanced Nursing Practice (American Association of
Colleges of Nursing, 2006). With the increased need to improve patients’ care, improve
patients’ safety and quality of life, the use of evidence-based practice continues to be the
focus of providing patients’ care in nursing practice. Conducting a systematic review of
the use of CHG dressing to reduce the CLABSI rate yielded the highest evidence of why
the intervention is superior compared to the general standard central line dressing. The
project promoted the need for more application of evidence-based practices in the
provision of care in nursing. The review provided a clear answer to why the dressing
should be a priority if the cases of CLABSIs will be reduced or brought to zero. The
project added knowledge to the healthcare providers and other stakeholders of why to
advocate for practices that have been proved to be of high quality to increase patient
safety (Connor, Paul, McCabe, & Ziniel, 2017).
Health care decisions making should be guided by the best available research
evidence. By practicing using the best evidence-based medicine, the health care providers
integrate their clinical expertise with the best available external clinical evidence from the
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systematic literature review and patient’s values and expectations. In this sense, the
external clinical evidence was retrieved from the available literature, and the evidence
was synthesized to answer the clinical question. The use of available evidence extracted
from exploiting the medical research on how a particular intervention has been practiced
obtaining an intended outcome and synthesize that information as a raw data are in a
typical experiment and is essential when conducting a systematic review. The advantage
of a systematic review in guiding the implementation of a particular intervention is that it
provides the health care providers or facility with an easy to read summarized findings of
all relevant individual studies over a health-related issue. The systematic review aims to
identify, evaluate, and synthesize the results of all relevant individual studies and make
the evidence available and easily accessible to decision-makers who may not have
enough time to look at different articles while making decisions in their patients’ care
(Gopalakrishnan & Ganeshkumar, 2013).
Transferability to Similar Practices
Better patients care involves the integration of evidence-based practice that is
obtained through research and the clinician expertise combined with best patient values to
produce positive patients’ outcome. The use of evidence-based practice has been
effectively emphasized as the most and effective method for clinical decision making to
improve patients’ health and reduce health care cost. The evidence-based practice of
reducing the CLABSIs can be used in other critical cares units or hospitalized patients
with the central venous catheter. The results of this systematic review can be shared with
other similar critical care units within the health care system, or in other patients with the

14
central venous catheter in the local city, state or at the national level. With the increasing
need to have evidence-based practice in health care, having medical evidence based on
credible literature and forms as a basis of clinical and policies decisions making is
important. Those who contribute to the synthesis of evidence as in the case of systematic
review should ensure that the information is accurate and unbiased. The systematic
review is a form of research and therefore maintaining the integrity of evidence retrieval
is an important ethical issue that should be considered. Bearing in mind that the evidence
synthesized will be used to implement interventions that are meant to improve human
care, the evidence obtained should be of high quality and the reviewer should be
transparent in the systematic review process in a manner that can be reproducible, and
results can be applied in other settings other than the local facility with the clinical
problem. Any potential conflicts of interest should be declared to ensure that the reviewer
was not influenced by certain individuals or companies to make recommendations based
on the available published literature. All the information that was used to guide the
systematic review was obtained from published literature, and there is no conflict of
interest when conducting the systematic review to recommend the use of adhesive
transparent CHG Tegaderm™ gel dressing (Wager & Wiffen, 2011).
Implications for Positive Social Change
Reducing the rate of unwanted and preventable deadly infections preserve life and
save billion dollars that are spent to treat infections such as CLABSI. Having an
intervention that is aimed in the prevention of CLABSI and is evidence-based supported
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with the highest level of evidence will be applicable and contribute in filling the gap that
exists to prevent CLABSI hence will add to positive change.
Summary
In section 1, I provided background information for the systematic review project.
I outlined the project question, the use of the study, the nature of the study, and the
importance of decreasing the CLASBIs. I explored the highest level of evidence to justify
why the use of adhesive transparent chlorohexidine gluconate Tegaderm™ is superior in
reducing the CLASBIs compared with the standard Biopatch® dressing. In the next
section, I will explore the supporting framework and the background information to
support the project.
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Section 2: Background and Context
Introduction
The use of evidence-based practice is the best guide and framework of nursing
practice to improve the patients care for optimum patients’ outcome. The use of
evidence-based is the new innovative approach in addressing the complex and needed
daily needs of the patients served (McEwen & Wills, 2014). The focused practice
question in my study was: “Does the use of adhesive transparent chlorohexidine
gluconate Tegaderm™ for adults above 18 years of age admitted to acute and critical care
unit with the central venous catheter decrease the CLABSIs rate?” My aim in this
doctoral project was to search, retrieve, analyze, synthesize and summarize the best
evidence-based practice in the reduction of CLABSI in acute and critical care units.
CLABSIs infections are common in hospital settings, especially in acutely ill
patients. CLABSIs are among the deadliest HAIs that occur daily and are considered as
noncompensated incidences by Medicare and Medicaid. Chlorohexidine gluconate
Tegaderm™ gel central line dressing has been shown to reduce the rate of CLABSIs in
adult in critical care units, but it remains unused despite the supporting evidence.
Therefore, in this section, I will discuss the practice-focused question and the use of the
theoretical framework/model to guide the systematic review. I will also discuss the
relevance of the project to nursing practice, the background information of the project,
and my role as the Doctor of Nursing practice (DNP) student in the project.
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Concepts, Models, and Theories
Theoretical Framework
The need to have evidence-based practice in the health care is to guide the health
care professionals based on the latest evidence and scientific development based on
research. The evidence-based in this project was the use of adhesive transparent
chlorohexidine gluconate gel Tegaderm™ dressing to decrease the CLASBI rate. The
practice-based evidence enables the clinicians or health care professionals to generate
knowledge from practice and research. The practice-based concept enables the clinicians
to integrate clinical experience and research evidence to make a sound clinical judgment
when caring for patients with a central venous catheter to reduce the CLABSIs (McEwen
et al., 2014).
Reducing the rate of health care-acquired infection is an essential aspect of
nursing practice. Reducing HAI does not only avoid the health care burden but also
reduce the mortality and morbidity of the patients. In this project, the logic model served
as a theoretical framework toward the systematic review of how CHG Tegaderm™ gel
central line dressing can reduce the rate of CLABSIs compared with the standard
Biopatch® dressings. Logic model is also known as a roadmap, theory of change, or
model of change, is a graphic depiction that represents the activities and the intended
outcomes of the program (see Figure 1 in Appendix D). The use of logic model helped to
articulate the current situation of CLABSIs and how a different intervention that is not
currently being practiced can contribute to the reduction of CLABSIs (CDC, n.d.). The
use of the logic model helped to provide a visual approach for the project by aiding in
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identifying the flow of the project, the goals, resources or inputs to meet the goals of the
project, the output needed to complete the goals, the project outcomes and the effects of
the project (Kettner, Moroney, & Martin, 2017).
The advantages of using logic models in the systematic review of the literature are
because they aid in helping the reviewer to think critically during the review process. It
also assists in identifying the inclusion and exclusion criteria, and guide how to research
the literature. Logic models aid in defining the outcomes of the review, identifying the
mediating and moderating factors, and disseminate the findings once the study
completed. The use of logic models in this systematic review of literature helped to
articulate how the intervention of CHG Tegaderm™ dressing can help decrease the rate
of CLABSI in the acutely ill patients. The model helped to explain how intervention
affects a change (Kneale, Thomas, & Harris, 2015).
Concepts/Terms Used in Doctoral Project
1. Tegaderm™: A transparent medical dressing that is used to cover and protect
wounds or catheter sites (Madhav, Matthew, & Edward, 2018).
2. Biopatch®: A protective Disk with CHG dressing for reducing infections and
skin colonization of microorganisms (Nicholls, 2014).
3. Central venous catheter: An intravascular venous catheter that is placed at or
close to the right side of the heart. The catheter is used in infusing medicine or
blood, drawing blood, administering medications and antibiotics,
administering fluids, and for hemodynamic monitoring (Bonne, Mazuski, &
Schuerer, 2015).
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4. Health care-associated infection (HAI): An infection that develops when a
patient has cared in health care settings such as the hospital, outpatient clinic.
The disease is associated with the care being delivered by a health care
provider (Bonne et al., 2015).
5. CLABSI: A primary bloodstream infection that is associated by the presence
of a central line or umbilical catheter within 48 hours before, onset of the
infection, with no other source of infection evidence other than the catheter.
The infection can happen any time regardless of the time the catheter is in
place (Bonne et al., 2015).
Relevance to Nursing Practice
History of the Problem in Nursing Practice
The use of evidence-based practice to solve the problem is critical in the decision
making in the health care and nursing practice. Many interventions in the care of the
patients are now correlated with the recent evidence-based practice that has been proven
to be effective. With the increase in the demand for better quality care in the provision of
care, an increasing need exists for using evidence-based practice in the nursing field in
the health care decision making. There is an increased need to use interventions based on
the evidence-based practice. Many organizations that support high-quality patients’ care
and high level of nursing care such as the Magnet Recognition Program of the American
Nurses Credentialing Center are dwelling on the use of evidence-based practice to be
applied in the daily nursing practice. The Institute of Medicine recommends the use of
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evidence-based practice to be integrated into the care of the patients or nursing practice
by the year 2020 (Institute of Medicine. 2010).
Nurses play a crucial role in the prevention of infections especially nosocomial
infections such as the CLABSIs. CVC have become indispensable in health care today
because of their critical use in the management of patients’ health such as the patients
who are critically ill. CVCs help in hemodynamically monitoring of acutely ill patients,
medication administration and delivering parenteral nutrition. When they are inserted,
they break the skin integrity as the first line of defense for fighting infection among
others. Thus, patients are exposed to the most frequent cause of nosocomial infections
known as CLABSI. CLABSI is considered a National Patient Safety Goal by the Joint
Commission of Healthcare Organization (“Hospital National Patient Safety Goals”,
2017). Nurses as the frontline providers of care to their needy patients make a significant
impact in reducing CLABSI and thus improves quality and safety of the patients’ care
and affect the financial stability of the health care organization.
The patients’ safety challenges to reduce the number of preventable CLABSI that
occur 4 days beyond the insertion of the central line are detrimental to the patients’ lives
and add hefty cost to the facility and the health care. When the facility spends money on
unnecessary incurrence that could be prevented, it impacts the budget assigned to the
unit, and this affects the nursing unit directly and indirectly. I remember working as a
bedside staff nurse, and sometimes we were told that our budget was tight because our
staffing, expenses are over the budget allocated to the unit. Cutting unit budget can affect
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the nurses’ morale, lack of equipment’s to work with, and this will lead to poor service
delivery.
Current Nursing Practice for Central Venous Catheter
Many facilities follow the central venous catheter bundles that incorporate
evidence-based science into practice in the care of CVC. The bundles have guidelines
that should be followed and the application of Biopatch® with standard central line
dressing during CVC insertion and dressing changes. Despite these bundles and proper
adherence, CLABSI incidences are still high. Having an intervention that can reduce the
CLABSIs to almost zero is a significant intervention that can be applied to the hospital
and contribute positively to the nursing practice. As caring professionals, nurses have
always saddened if the patients die because of an infection that could have been
prevented. The use of CHG Tegaderm™ has been proven to be useful in the prevention
of CLABSIs. Therefore, the project will contribute positively to the nursing practice.
Previous Strategies
Despite the CDC and the Healthcare Infection Control Practices Advisory
Committee (HICPAC) guidelines on caring for the central venous catheter, the rate of
intravascular catheter-related infection such as CLABSI is still rampant. Many hospitals
abide by the CDC and HICPAC’s central lines guidelines and performance improvement
strategies by implementing the central line bundle strategies as outlined by the CDC, but
the rates of CLABSI are still high. Therefore, the review of the literature provided
enough evidence to support the use of chlorohexidine gluconate Tegaderm™ gel.
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How the Doctoral Project Advances Nursing Practice
CLABSIs are detrimental to the life of the already acutely ill patients whose their
immune system is very fragile. Being a nosocomial infection, the issue of how a unit or a
hospital can be able to prevent CLABSI completely to zero in 1000 days remains a
challenge. The current bundles are applied to almost every hospital and emphasized each
day on how to prevent this deadly disease. Despite these measures, CLABSIs are still
rampant and contribute to mortality and morbidity of many citizens and contribute to a
huge financial burden on the already burdened health care system. Therefore, conducting
the systematic review on an evidenced-based practice that can be applied to reduce the
cases of CLABSI filled the gap that already exists in the nursing practice on the best
method or effective method to reduce CLABSI cases. The doctoral project shed light with
an intervention that is evidenced-based backed with the highest evidence from the
literature.
Local Background and Context
Local Evidence on the Relevant of the Practice Problem
Decreasing CLABSIs is essential for nursing practice especially with a facility
that is aiming for Magnet designation and to decrease the mortality and morbidity
associated with CLABSI. Money that spent on treating CLABSI can be used to buy state
of the art equipment that facilitates a favorable environment for nursing staff.
Tegaderm™ CHG is easier to use and reduces the rate of infection and the evidence I
obtained proved that the dressing is preferred in the clinical settings by the end users. The
local facility is targeting to transition from the standard CVC dressing to the Tegaderm™
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CHG gel if there is enough evidence to convince hospital leadership that the latter is
better than the regular dressing. Also, the goal of the local critical care unit is to have less
than five CLABSIs per 1000 central line days. Due to the increase in the number of
CLABSIs in spite of the local critical care unit adherence to the CDC central venous
catheter bundle guidelines, there is need to find solutions that can help improve the care
of the CVCs in the hospitals. I formulated a practice-focused question to find the best
evidence to back the recommendations of the use of an adhesive transparent
chlorohexidine gluconate Tegaderm™ gel dressing on how it is superior to decrease the
rate of CLABSIs. Therefore, my doctoral project involved conducting a systematic
review of the literature to answer the practice-focused question of “Does the use of
adhesive transparent chlorohexidine gluconate Tegaderm™ for adults above 18 years of
age admitted to acute and critical care unit with the central venous catheter decreases the
CLABSIs rate?”
Institutional Context on the Relevant of the Practice Problem
The practicum site I carried the project is a critical care unit in a local acute care
hospital in Dallas, Texas. The critical care unit has 64 beds in a hospital of more than 500
inpatient beds. The practice question was developed as a request by the critical care team
leadership request to conduct a systematic review of the literature to find the available
evidence that supports the impacts of CHG Tegaderm™ central line dressing compared
to the traditional Biopatch® dressing. The local critical care unit has current CLABSI
rate of 0.962 and the whole hospital has a CLABSI rate of 1.232 for the current fiscal
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year starting October 1st, 2017 to September 30th, 2018. The critical care leadership in the
local hospital had identified the need:
1. To decrease the numbers of CLABSIs per 1000 central line days.
2. To achieve the target goal 0.641 per fiscal year.
Nurses who work in the unit and have part-time jobs in other hospitals have
explained how one of the hospitals in Dallas, Texas has implemented the use of CHG
Tegaderm™ gel dressings and within 1000 hospital days, the unit had a lower rate of
CLABSIs per 1000 central venous catheter days for a critical care unit with 50 beds. To
convince the management to change the central line dressing from the standard
Biopatch® dressing, the critical care unit needed enough evidence and investigation to
prove that the CHG gel Tegaderm™ dressing is superior in reducing the CLABSIs.
Therefore, I formulated the above practice question to investigate and reviewed literature
for the evidence of how CHG Tegaderm™ is excellent in the reduction of the CLABSIs.
State and Federal Context of the Problem
CLABSIs are reportable health care-associated infections (HAIs) in both the state
and the national level. The Texas Department of Health and Human Services requires
health care facilities to report HAI through a reporting database called the National
Healthcare Safety Network (NHSN), maintained by the Division of Healthcare Quality
Promotion (DHQP) at the CDC. The standardized infection ratio (SIR) is a new method
that is being used in summarizing HAI experiences across any number of health care
facilities or any types. The advantage of SIR is that it can assess HAIs at a national, state,
or local level. For adults in ICU, the CLABSI risk adjustment uses patients’ care location,
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bed size of the patients’ care location and hospital affiliation with a medical school to
determine the risk of acquiring an infection (Malapiedi, 2013). To calculate CLABSISIR, the total number of observed CLABSI events is divided by the predicted number of
CLABSI events based on the national CLABSI rates. The predicted number of CLABSI
events is calculated by multiplying the national CLABSI rate by the number of central
line days that occurred in the hospital unit and divide by 1000. The CLABSI rate is per
1000 central line days. For instance, if the number of national CLABSI rate is five, and
the number of CLABSI in the above facility is 10 in 1000 days, then the predicted
number of CLABSI for this unit is,
(Observed central line days) * (National rate) = (1000) * (5.0) = 5.0
1000

1000

5.0 is the number of expected/predicted CLABSIs for this location at this hospital.
Therefore, to calculate the SIR

SIR = (Observed # CLABSIs) = 10
(Predicted # CLABSIs)

= 2.0
5

If the SIR is greater than 1, it means that the health care facility has more HAI
than the national baseline, meaning it is doing worse than the national experience and
vice versa (Malapiedi, 2013).
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Role of the DNP Student
Student Professional Context

I am currently practicing as an adult-gerontology acute care nurse practitioner at a
correctional facility in a large city in Texas. Although my current role doesn’t involve
patients with central venous catheter, my previous nursing background was in critical
care unit where I helped clinicians’ insert central venous catheter and I directly was
involved in assessing and changing the central venous catheter dressing. My practicum
site was my former work place and therefore, I have experienced patients developing
CLABSIs during my direct bedside nursing career at the practicum site. As a former
critical care nurse, I have observed patients developing CLABSIs due to the infected
central line catheter.
Role of the Student in the Doctoral Project

The American Association of Colleges of Nursing describes eight essentials that a
doctoral-prepared nurse attains upon graduation from a doctoral program. The Clinical
Scholarship and Analytical Methods for Evidence-Based Practice (Essential III) is one of
the essential that I have applied in this doctoral project. Turning original research to
evidence-based practice and use the evidence to solve the clinical problem is a significant
hallmark of doctoral education (American Association of Colleges of Nursing, 2006).
Doctoral prepared nurses should take the lead to foster changes at the organization level
national level, nursing practice, and health care at large. With the skills, knowledge, and
experience I have learned during the doctoral program, I have applied them while I
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conducted a comprehensive systematic review of the literature to find answers to the
question raised above. My role in this project was the primary sole researcher and
evaluator of the highest level of evidence, identified the evidence attained, appraised the
evidence for inclusion in the review and determined the quality of the evidence retrieved.
I also synthesized the evidence obtained making easy to read and comprehend and more
natural to be applied into practice to solve the clinical problem.
Motivation for the Doctoral Project

Throughout the doctoral program, the use of evidence-based practice has been
emphasized in almost every class I have taken during my doctoral studies. As a doctoral
prepared nurse, it is essential to always aspire to improve the knowledge and lead in the
adoption of the evidence-based practice in our nursing practice as leaders and scholars.
As an advanced nurse practitioner, it is my aspiration to improve the care of the patients
and be a mentor to the novice nurses in the improvement of patients’ care and how
nursing is practiced. I am determined to find the best evidence that will support the
clinical question in my endeavor as a scholar and practitioner. As a former critical care
nurse, I have observed patients developing CLABSI due to the infected central line
catheter. I have assisted clinician insert a central line and have changed the central line
dressing multiple times. The Biopatch® used with the standard central line dressing is
supposed to prevent central line infection, but because the material is opaque, it is hard to
assess the site of the insertion. Failure to use it in the standard dressings leaves the site
with no antibacterial coverage. Some facility such as a one unit I worked at had opted not
to use the Biopatch® so the clinicians can have easy access to the insertion site. This is
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not the best practice, because it leaves the site open for microbial organisms that are
microscopic to view with bare eyes. The advantage of Chlorohexidine Tegaderm™ gel
dressing is that it will enable the health care providers to assess the site at the same time
having antimicrobial activity that helps protect the central line and the patients. To
achieve zero or decreased numbers of CLABSI in 1000 central line days is at the heart of
every nurse and the health care facilities and this is why finding the highest level of
evidence to support this evidence-based practice is paramount.
Potential Biases

Biases can arise during a study and can be introduced at any point during a study.
Sticking to the highest level of evidence and avoiding any opinions from stakeholders or
non-expert ensured yielding better results in the systematic review of the literature. Also,
ensuring that the systematic review is supported by the highest level of evidence such as
meta-analysis and systematic review of randomized clinical trials randomized critical
trails studies and non-randomized clinical trials ensured minimal bias of the studies.
Ensuring that the process was transparent and indicating the process of retrieving and
arriving at the selected articles to form the evidence to answer the clinical question
ensured the process was clear and it is reproducible (Melnyk, & Fineout-Overholt, 2011).
Role of the DNP Project Team

The project team for this doctoral project is the critical care nursing leadership,
practicum mentor, and the critical care unit-based council. After completion of the
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doctoral project, I will present the findings to the critical care team. I solely conducted
the systematic review of literature.
Summary
Section 2, I provided the theoretical framework that guided the project and I
discussed the local background of the project and why I conducted it. I also identified the
impact of the study in the nursing practice and the role I played in the development of the
project. In the next section, I will reframe the question of the study and provide the
literature support and the synthesis of the evidence.
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Section 3: Collection and Analysis of Evidence
Introduction
The Problem and the Purpose
Central venous catheters are essential in the critical care unit because of the
ability to administer fluids, blood, antibiotics, parenteral nutrition, and hemodynamic
measurement. Due to their proximity to the heart, the chance of causing infection is very
high. Biopatch® dressing has been widely used in many years as part of the central line
management bundle, but the infection rate continues to rise or never been eliminated
regardless of how thorough and sterile the insertion and dressing change of the central
line is. The use of transparent Tegaderm™ with CHG is new and has been proved to be
more superior to the traditional standard Biopatch® dressing. Due to the cost of treating
CLABSI, which is considered as a hospital-acquired infection (HAI) and the morbidity
and mortality associated with CLABSI, finding a solution on how to decrease the rate of
CLABSIs or prevent them is crucial not only to the local health care facility but the
nursing practice at large. The systematic review of the literature enabled retrieval of the
highest evidence to support the use of adhesive transparent chlorohexidine gluconate
Tegaderm™ for adults above 18 years of age admitted to critical care unit with a central
venous catheter to prevent CLASBIs. My purpose in this doctoral project was to conduct
a systematic review of the literature to find the highest level of evidence to fill the gap
that still exists in preventing CLABSIs in acute and critical care settings. In section 3, the
focus will be on the practice-focused question, source of evidence, systematic review
methodology, and the analysis of evidence (Jenks et al., 2016).
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Practice-Focused Question
The Local Problem, Gap in Practice and Focused Question
Central venous catheters are widely used in intensive care units to administer
drugs or fluids. The use of Biopatch® with central line dressing has been widely used for
years, but the CLABSIs rates are still high. Recently, there is a new intervention that is
using Tegaderm™ with CHG gel, which is transparent, and adhesively secures the central
line site and allows the clinicians to view the site. The water-vapor-permeable CHGimpregnated gel pad is incorporated onto the adhesive side of a transparent polyurethane
dressing, and the CHG-impregnated gel pad is applied directly over the insertion site at
the time of catheter insertion or during follow up site care. The gel rapidly softens at skin
temperatures and flows about the catheter, providing intimate contact of the CHGimpregnated surface with the entire insertion site. The gel also absorbs up to eight times
its weight in fluid, preventing accumulation of moisture on the site. The integrated
dressing tightly secures the catheter, preventing any positioning movement that can
facilitate entry of microorganism into the insertion tract (Maki et al., 2008). The dressing
acts as a barrier against external contamination, and the gel pad has an antiseptic agent.
The use of CHG-impregnated dressing placed during the time of CVC insertion and
dressing changes ensures the dressing to release the chlorhexidine onto the skin for a 10day period. The reduction of CLABSI is an area that many hospitals are still struggling to
control.
The local hospital is still struggling with CLABSIs with most time doing worse
than the national average despite application of the central line bundles guidelines in the
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care of the central venous catheter. The critical care leadership team anticipates a
decrease in the rate of CLABSIs with the introduction of CHG Tegaderm™ gel instead of
the traditional Biopatch® dressing if approved by the administration and after having
clear strong supporting evidence. With the increasing need to provide the highest quality
and minimize the rate of central line infections, the gap in nursing on the reduction of
CLABSIs still exists on the best highest quality method that can be used to decrease or
have zero chances of CLABSIs. The purpose of this systematic review of the literature
was to evaluate why the use of transparent IV dressing with CHG gel is essential to
reduce the infection compared to the standard CVC dressing with Biopatch® during the
insertion and dressing changes. The result of the systematic review will be crucial to the
facility and the nursing practice to contribute to how the deadly disease can be prevented.
The systematic review of the literature allowed gathering evidence from different
sources. The evidence was broken down from the highest level to the lowest level to
answer the practice-focused question and only the level 1-3 according to the Melynk and
Overholt’s hierarchy of evidence (2011) were included in the review to minimize any risk
of bias in the studies.
The practice question that guided this systematic review of literature is: Does the
use of adhesive transparent chlorohexidine gluconate Tegaderm™ for adults above 18
years of age admitted to acute and critical care unit with the central venous catheter
decrease the CLABSIs rate?
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Clarifying the Purpose
My aim of conducting this doctoral project was to evaluate and synthesize the
available evidence-based research on the use of adhesive transparent chlorohexidine
gluconate Tegaderm™ and find why it is superior in the reduction of CLABSIs compared
to the traditional Biopatch® dressing. The approach to collect the evidence was guided
by the practice-focused question of “does the use of adhesive transparent chlorohexidine
gluconate Tegaderm™ for adults above 18 years of age admitted to critical care unit with
the central venous catheter decrease the CLABSI rates?” My aim was to gather data with
the strongest highest level of evidence to answer the practice-focused question and
support the use of adhesive transparent chlorohexidine gluconate Tegaderm™ as an
intervention that will be implemented in the clinical setting to solve the problem of
CLABSIs.
Sources of Evidence
The motive of conducting this project was to find, retrieve, evaluate, and
synthesize the best available published literature as evidence relevant to the new CHG
gluconate gel integrated transparent Tegaderm™ in the care central venous catheter that
is determined to be superior to the CHG Biopatch®. Due to the nature of the project, only
the published literature was used to answer the practiced focused question as the source
of data and evidence. The systematic review was guided by the practice-focused question
of, “does the use of adhesive transparent chlorohexidine gluconate Tegaderm™ for adults
above 18 years of age admitted to critical care unit with the central venous catheter
decrease the CLABSIs rate?” The aim of conducting this literature review was to
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evaluate and synthesize the best available evidence that was relevant to the use of
adhesive transparent chlorohexidine gluconate Tegaderm™ in the prevention of the
CLABSI rate. The source of evidence that I used to address and answer the practiced
focused-question came from the primary and secondary sources of peer-reviewed journal
articles from the databases mentioned below and the google scholar. I conducted a
comprehensive literature review using online databases and the Google scholar. The
following databases were used for the search of the current literature: Cochrane Database
of Systematic Reviews (CDSR), PUBMED, EMBASE, Cumulative Index to Nursing &
Allied Health Literature (CINAHL) and Medical Literature Analysis and Retrieval
System Online (MEDLINE) combined search, ProQuest Nursing and Allied Health
Source database, and Google Scholar. The search was exhaustive and comprehensive.
The inclusion criteria were articles published within a period of 10 years old from 2008
to 2018 focusing on central line infections, full articles published in English, full articles,
and focus on adults. Articles older than ten years were excluded from review, nonEnglish articles and articles dealing with pediatrics or younger than 18 years of age.
Relationship of the Evidence to the Purpose of the Project
After searching the literature, 249 articles from databases and 124 from google
scholar were obtained and 211 articles were left after removing the duplicates. The
abstracts and references of the remaining 211 articles were screened and 165 articles
were excluded as they did not meet the inclusion criteria, or they were found to be
irrelevant to the study. Twenty-seven full articles were selected and 16 met the inclusion
criteria for the final inclusion and 11 articles were excluded with reasons given as

35
detailed in the exclusion table (see Table 3 in Appendix C). The inclusion criteria for this
systematic review included (a) articles addressing adults older than 18 years in acute or
critical care hospital with the central venous catheter that has CHG Tegaderm™ dressing,
(b) full-text articles, and (c) articles published between 2008 and 2018 and in the English
language. The evidence obtained after an extensive search of literature helped to connect
the purpose of this doctoral project to evaluate why the use of transparent IV dressing
with CHG gel is an evidence-based recommendation to reduce the infection compared to
the standard CVC dressing with Biopatch® during the insertion and dressing changes.
The comprehensive and exhaustive search process resulted in 16 full articles that met the
inclusion criteria and were used in this systematic review. The initial search of the
literature started in the CINHAL with MEDLINE combined with the initial word used
was the central venous catheter. The results of the systematic review will be essential to
the facility to help meet the core measures as a quality indicator and reduce the
unnecessary costs to treat CLABSI infections. The review will also be significant to the
nursing practice to contribute to how the deadly disease can be prevented. The evidence
retrieved from the literature is strong to validate the use of adhesive transparent
chlorohexidine gluconate Tegaderm™ in reducing CLABSIs as the best practice that is
supported by the literature and superior to the tradition Biopatch® dressing.
Evidence to Address the Practice-Focused Question
The collection and analysis of the evidence helped to answer the practice-focused
question of the doctoral project. The articles selected were those retrieved after the search
words were used in the databases identified above and the google scholar and those that
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met the inclusion criteria established before the collection of data from the online
published literature. The search words used to retrieve data were: the central venous
catheter, Tegaderm™ CHG gel, adult critical care, bloodstream infection, CHG dressing,
and the CLABSIs, and CHG Tegaderm™ gel. After collecting the evidence and the
articles that met the criteria were selected, Fineout-Overholts hierarchy of evidence was
used to synthesize and critically appraise the evidence obtained to answer the practicefocused question. The evidence table covers the type of evidence, levels of evidence, and
the description of evidence (Melnyk & Fineout-Overholt, 2011). The collection and
analysis of the obtained evidence helped to address the benefits and effectiveness of
using CHG gel Tegaderm™ dressing in the central venous catheter in the reduction of
CLASBIs.
Research Method
The research method was a systematic review of the literature to retrieve evidence
from published literature from online databases and google scholar. The pre-defined
practice focused question guided the finding of the evidence and retrieving the evidence
based on the inclusion criteria defined by the practiced focused question. After approval
by the university review board to collect data for the doctoral project, I used different
databases using the Walden University Library and Google Scholar to retrieve articles
using the search terms such as the central venous catheter, Tegaderm™ CHG, standard
intravenous dressing, adult critical care, bloodstream infection, chlorhexidine gel
dressing, and central-line related bloodstream infection (CLABSI). I used different
databases such as the Cochrane Database of Systematic Reviews (CDSR), National
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Library of Medicine (NLM), PubMed Health, Biomed Central, Cumulative Index to
Nursing & Allied Health Literature (CINAHL), Joanna Briggs Institute EBP Database,
ProQuest Nursing and Allied Health Source database and Google scholars to search the
evidence.
Published Outcomes and Research
Databases and Search Engines
I assessed articles to answer the practice-focused question from the following
databases: Cochrane Database of Systematic Reviews (CDSR), PUBMED, EMBASE,
Cumulative Index to Nursing & Allied Health Literature (CINAHL) and Medical
Literature Analysis and Retrieval System Online (MEDLINE) combined search,
ProQuest Nursing and Allied Health Source database, and Google Scholar. I used Walden
University online library and search engines such as the Google Scholar to assess the
articles that met the criteria for the practice focused question.
Key Search Terms
The search terms and word combinations that used included a central venous
catheter, Tegaderm™ CHG gel, standard intravenous dressing, adult critical care,
bloodstream infection, chlorhexidine dressing, and CHG gel Tegaderm™, and CLABSIs.
The Scope of the Review
My aim of conducting an extensive literature search was to find and gather
relevant information that is related to the use of transparent IV Tegaderm™ dressing with
CHG gel to reduce the CLABSIs. The inclusion criteria were articles published within ten
years (between 2008-2018) and published in English language, meta-analysis articles,
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randomized controlled trials, controlled clinical trials, and non-randomized controlled
trials before and after studies. The demographic characteristics of the population who
qualified for inclusion were adults above 18 years of age in acute and critical care units
and clinicians working in acute and intensive care units. The Exclusion criteria were
patients with already existing bloodstream infections and under the age of 18 years of
age.
Exhaustive and Comprehensive Search
Searching for the literature was exhaustive as I used different databases by using
different terms and phrase combinations that covered the practice-focused question and
the population of patients above age 18 years. The articles that I selected were read in full
to find which one met the inclusion criteria and exclusion criteria. I conducted an
exhaustive search and retrieval of literature in that after removal of duplicates I read all
abstracts and references of the articles to make sure there was no chance of missing
important information during the search for the best highest level of evidence to answer
the practice question.
Institutional Review Board
The systematic literature review does not have direct involvement of human
subjects, and therefore, the issue of human rights did not apply in this doctoral project.
Furthermore, after approval of the proposal oral defense by the committee chair and
members, I contacted the Walden University institutional review board to obtain an
authorization to conduct the systematic review of the literature to ensure that all rights
were protected. The data of the study was from the published literature. As the study
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project was an institutional review board pre-approved for DNP Systematic Literature
Review, the IRB approved the implementation of the proposal with approval number 0912-18-0572544.
Analysis and Synthesis
Systems to Record, Track, Organize and Analyze the Evidence
After retrieving the articles, those that met the criteria were reviewed thoroughly,
evaluated and analyzed using the Melynyk and Fineout-Overholt (2011) seven levels of
evidence (see Table 1). I manually organized and recorded the evidence obtained from
the search of the literature in a Microsoft Word Matrix table (see Table 2 in Appendix A).
Articles were organized into various columns by the year of publication and the name of
the author(s), the title of the articles and the purpose of conducting the study, the research
design used the sample size of the subjects and settings, the findings of the study or
outcomes and the level of evidence. Each article was weighed against each level of
evidence below and categorized accordingly. The findings of the articles are summarized
in the finding section within each level for illustration and individual summary of the
articles.
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Table 1
Levels of Evidence

The preferred reporting item for systematic reviews and meta-analysis (PRISMA)
flowchart diagram was used to illustrate the procedure to select the articles (McInnes et
al., 2018) (see Figure 2 in Appendix D).
Analysis Procedure
The evidence that I obtained during the search of the literature was categorized
based on the strength of evidence of the study. The highest or the most substantial level
of evidence was used to propose the use of adhesive transparent chlorohexidine gluconate
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central line dressing in the reduction of CLASBIs. The data analysis obtained was used to
recommend the use of adhesive transparent chlorohexidine gluconate central line
dressing.
Summary
The aim of conducting this systematic review project was to provide the
recommendation that can yield significant help in addressing the gap that still exists in
the prevention of CLABSIs. The results of conducting this systematic review shed light
on the advantages of using the adhesive transparent chlorohexidine gluconate central line
dressing compared to the traditional Biopatch® dressing in the prevention of CLABSI to
improve patient care quality and reduce the mortality and morbidity associated with
CLABSIs. The outcomes of the study will benefit the local facility and the nursing
practice as well as improve the patients’ care outcomes in adult in both acute and critical
care units. The adhesive transparent chlorohexidine gluconate central line dressing
project has the potential to decrease the numbers of CLABSI in acute and critical care
units that will improve the patient safety and clinical outcome in health care
organizations when the recommendation is implemented. In this section I discussed the
practice-focused question, the source of evidence, the Walden University institutional
review board process, and the analysis and synthesis of the evidence that was obtained. In
the next section, I will discuss the introduction of section four, the findings and
implications of the extensive search of the literature, recommendations, strength, and
limitations of the systematic review.
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Section 4: Findings and Recommendations
Introduction
Central venous catheters are widely used in intensive care units and acute
hospitals to administer drugs or fluids. The populations in adult intensive care units are
critically ill and susceptible to infection. When catheters are introduced into the patients’
bodies, they become an easy port of bacterial entry if proper care is not taken. The CDC
requires health care facilities to use the CDC guideline issued in 2011 for the prevention
of CLABSI. The CDC requires the health care facilities to:
1. Educate and train health care personnel who insert and maintain catheters.
2.

Use maximal sterile barrier precautions during central venous catheter
insertion.

3. Use a > 0.5% CHG preparation with alcohol for skin antisepsis.
4. Avoid routine replacement of central venous catheters as a strategy to prevent
infection.
5. Use antiseptic/antibiotic impregnated short-term central venous catheters and
chlorhexidine-impregnated sponge dressings if the rate of infection is not
decreasing despite adherence to other strategies (i.e., education and training,
maximum barrier precautions, and > 0.5% chlorhexidine preparations with
alcohol for skin antisepsis).
6. Perform improvement by the implementation bundled strategies, and
documenting and reporting rates of compliance with all components of the
bundles as benchmarks for quality assurance
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(Adapted from the Center for Disease Control and Prevention (2011).
Evidence-based practices are essential to inform the practice and care that nurses
provide to patients each day. The absence of the best central line dressing in caring for
adults’ patients with the central venous catheter has led to the increase of the CLABSIs
despite adherence to the CDC (2011) guidelines. The local hospital applies the 2011 CDC
guidelines with an aim in preventing the CLABSI. After the central line insertion or
during the dressing change, a chlorhexidine-impregnated sponge (Biopatch®) is applied
at the site of insertion and covered with a sterile, transparent, semipermeable dressing per
the 2011 CDC guidelines (CDC, 2011). There is a central venous catheter dressing called
adhesive transparent chlorohexidine gluconate Tegaderm™ gel. The dressing is new in
the market and has proved to be superior to the current standard dressing used (CHG
Biopatch®/Sponge/Disk), but little is known about it. The need to have clear and robust
evidence to propose the change of dressing for the local facility to decrease the rates of
CLABSI prompted the decision to conduct a systematic review of the literature to find
the evidence of why the proposed dressing is superior to the one currently being used.
The gap in nursing practice still exists on the best method or best dressing for the central
venous catheter to control CLABSIs. The purpose of this systematic review of the
literature was to synthesize evidence relevant to the use of Adhesive Transparent
Chlorohexidine Gluconate Tegaderm™ Gel Dressing to improve the control of CLABSI
when implemented with the CDC 2011 guidelines for the central venous catheter.
The practice-focused question that guided the DNP project was: “Does the use of
adhesive transparent chlorohexidine gluconate Tegaderm™ for adults above 18 years of
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age admitted to acute and critical care unit with the central venous catheter decrease the
CLABSI rate?” Articles from databases such as CINHAL, MEDLINE, PubMed,
EMBASE, and Google Scholar were used as evidence to support the systematic literature
review. Only articles that met the criteria were included for the review, and those that
didn’t meet the criteria were excluded with the reason for exclusion as is indicated in the
table of exclusion (See Table 3 for Full Articles Excluded, in Appendix B).
With the need to provide current evidence-based quality of care, it is imperative
for doctoral prepared nurses to be in the front line to have projects that are guided to
improve how care is being delivered to have an impact to the patients, health care
providers, facility, and the nursing practice. As a doctoral student, I embarked on a
systematic review project on the use of adhesive transparent CHG Tegaderm™ gel
dressing for the central venous catheter that has been proved to be superior compared to
the chlorhexidine Biopatch® in decreasing the central-line associated bloodstream
infections. The project involved formulating a research question that guided the search
words, the inclusion criteria, retrieval and synthesis of the findings to form the evidence
to answer the clinical question. Health care decisions making should be guided by the
best available research evidence. By practicing the best evidence-based medicine, the
health care providers integrate their clinical expertise with the best available external
clinical evidence from the systematic literature review and patient’s values and
expectations. In this essence, the external clinical evidence was retrieved from the
available literature, and the evidence was synthesized to answer the clinical question. The
systematic review involves conducting an extensive published literature search, evaluate
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the evidence, and synthesize the evidence to be used as supporting evidence to guide
nursing practice. The advantage of a systematic review in guiding the implementation of
an intervention that a health care provider or facility is intending to implement the
intervention is that it provides quickly summarized findings of all relevant individual
studies over a health-related issue. The aim of the systematic review is to identify,
evaluate, and synthesize the results of all relevant individual studies and make the
evidence available and easily accessible to decision-makers who may not have enough
time to look at different articles while making decisions in their patients’ care
(Gopalakrishnan & Ganeshkumar, 2013).
The search terms and word combinations I used to search for evidence included
the central venous catheter, Tegaderm™ CHG, adult critical care, bloodstream infection,
chlorhexidine dressing, CHG gel Tegaderm™, and CLABSIs. The only data included are
from those articles that met the criteria predefined before the search. After the appraisal
of the articles using the Melynk and Fineout-Overholt’s (2011) guide on the hierarchy of
evidence-based studies, I used the Microsoft Word Matrix Table to record the articles
selected. I later organized the articles into various columns by the year of publication and
the name of the author(s), the title of the articles and the purpose of conducting the study,
the research design used, the sample size of the subjects and settings, the findings of the
study or outcomes and the level of evidence (see Table 2, in Appendix A.). The purpose
of conducting this systematic review of the literature was to search, retrieve, record and
analyze the highest level of evidence available to answer the clinical question formulated
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before the start of the project and make recommendations for the local facility and to the
nursing practice.
To comply with the Walden University IRB, approval was obtained to collect data
with approval number 09-12-18-0572544.
In Section 4, I will discuss the synthesis and summary of the findings. Articles
that made through the inclusion criteria and evaluation are broken down in the level of
evidence and summary explained. The implications of this systematic review are
discussed, and recommendations are well defined. The strength and limitations of the
systematic review are identified and discussed in this section.
Findings and Implications
The literature search resulted in 249 articles from database and 124 from google
scholar based on the search terms. After removing duplicate, the 211 articles were left,
and their abstracts and references were fully screened. One hundred and sixty-five
articles were excluded as they did not meet the inclusion criteria, or they were found to
be irrelevant to the study. Twenty-seven full articles were selected and reviewed, out of
which 16 met the criteria for the final inclusion (See Table 2, Appendix A) and 11
articles were excluded with the reasons given as detailed in the exclusion table (see Table
3. Appendix B). The analysis resulted in (n= 16) articles that met the relevant review
criteria (see Appendix A). Eleven articles were excluded with the reason for exclusion
explained (see Table 3, Appendix B). The inclusion for this systematic review included
(a) articles addressing adults’ older than18 years of age in acute or critical care hospital
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with the central venous catheter that has CHG Tegaderm™ dressing, (b) full-text articles,
(c) articles published between 2008 and 2018 and in the English language.
The evidence obtained after an extensive search of literature helped to connect the
purpose of this doctoral project to evaluate why the use of transparent IV dressing with
CHG gel is an evidence-based recommendation to reduce the infection compared to the
standard CVC dressing with Biopatch® during the insertion and dressing changes. The
comprehensive and exhaustive search process resulted in 16 articles that met the
inclusion criteria and are used in this systematic review. The initial search of the
literature started in the CINHAL with MEDLINE combined with the initial word used
was the central venous catheter. The results of the systematic review will be essential to
the facility to help meet the core measures as a quality indicator and reduce the
unnecessary costs to treat CLABSI infections. The review will also be significant to the
nursing practice to contribute to how the deadly disease can be prevented. The evidence
retrieved from the literature is strong to validate the use of adhesive transparent
chlorohexidine gluconate Tegaderm™ in reducing CLABSIs as the best practice that is
supported by the literature and superior to the tradition Biopatch® dressing.
After retrieving the articles, I graded them using the Melynk and FinehoutOverholt system of grading evidence and grouped them based on their level of evidence.
The summary of the articles will be discussed below, and the complete literature review
table is found in Table 2, Appendix A.
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Level 1 of Evidence
In the Melynk et al., (2011) hierarchy of evidence the level 1 is considered as the
highest level of evidence and most powerful to provide the substantiate evidence with
minimal bias. The level 1 included in this literature review is the meta-analysis of
multiple randomized controlled trials.
Safdar et al., (2014) conducted a meta-analysis of multiple randomized controlled
trials to assess the efficacy of a chlorhexidine-impregnated dressing compared with
conventional dressing for prevention of catheter colonization and Cather-related
bloodstream infection. Only studies that were prospective randomized trials comparing a
chlorhexidine-impregnated dressing with conventional site care were considered for
selection. Nine randomized controlled trials met the criteria for inclusion in the metaanalysis. The studies enrolled 6,067 patients with a total of 11,214 catheterizations. A
total of 2,984 patients with 5,586 catheters received a chlorhexidine-impregnated
dressing and 3083 patients with 5628 catheters received conventional site care. A total of
361 of 5,586 catheters (6.5%) were colonized in the CHG gel group compared with 743
of 5,628 (13.2%) in the comparator group. The study concluded that the use of
chlorhexidine-impregnated dressing is beneficial in the prevention of catheter
colonization and catheter-related bloodstream infection and should be used in patients
that are at high risk for catheter-related bloodstream infection (Safdar et al., 2014).
Maunoury and colleagues (2015) conducted a meta-analysis of a multicenter
randomized controlled trial of 1,879 adults above 18 years admitted to 12 French ICUs in
seven universities and four general hospitals from 31st May 2010 to 29th July 2011 who
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required intravascular catheterization for 48 hours. A total of 4,163 catheters and 34, 339
catheter-days were studied. The objective of the study was to conduct a cost-effectiveness
analysis to determine the impact of the use of antimicrobial CHG-containing securement
dressing compared to non-antimicrobial transparent dressing for the reduction of
CLABSIs and other cost related to the CLABSIs. The analysis revealed a ratio of 1 to 5
for the average number of CLABSIs occurred between CHG and non-CHG dressings
groups respectively with 3 CLABSIs occurred in CHG group and 14 in the standard
group. The difference in the numbers of CLABSIs was highly statistically significant
(Maunoury et al., 2015).
Level 2 of Evidence
Level 2 is considered the second most powerful level of evidence in the hierarchy
of evidence according to Melynk et al., (2011). This level includes well-designed,
quantitative, randomized controlled trials. Timsit et al., (2012) conducted a multicenter
randomized controlled trial in 1,879 subjects with 4,163 central venous catheters in adults
above 18 years of age in patients in 12 ICUs in France that were required catheterization
for 48 hours between May 31st, 2010 to July 29th, 2011 to determine if chlorhexidineimpregnated Tegaderm™ and strongly adherent dressings decrease catheter colonization
and catheter-related infections. The study is considered as the landmark study that
evaluated and supported the use of transparent chlorhexidine impregnated gel dressing
with high holding power and reinforced border. Patients were randomized to one of the
three dressings: (1) a CHG dressing (Tegaderm™ CHG); (2) a highly adhesive dressing;
and (3) a standard breather bale, hypoallergenic dressing. These multiple randomized
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clinical trials found that the addition of 3M Tegaderm™ CHG I.V. Securement Dressing
in institutions already following routine infection control techniques led to a reduction in
catheter colonization and catheter-related infections. 21/941 (2.2%) patients in the control
group were found to have Infection with 1.29 infections per 1000 Catheter days while in
the CHG dressing group 9/938 (0.96%) of the patients had infections comprising 0.52
infections/1000 catheter days. The study revealed that there was a 57% reduction in
patients with infections and 60% reduction of infections per 1000 Catheter for the
patients using the CHG gel dressing (Timsit et al., 2012).
Pedrolo, Danski, and Vayego (2014) conducted a randomized clinical trial from
October 2011 to May 2012 to assess the effectiveness of the chlorhexidine antimicrobial
dressing in comparison to the gauze and tape dressing in the use of central venous
catheter in 85 severe clinical and surgical adults in intensive care and adult semiintensive care units of a university hospital in south of Brazil. Forty-three patients were
randomized in the intervention group (chlorhexidine antimicrobial dressing) and 42 in the
control group (gauze and tape dressing). The study did not find any statistical difference
in the reduction of primary bloodstream infections, local reactions to the dressing and
dressing fixation between the two dressings (Pedrolo et al., 2014).
Dolci, Margatho, Silveira, and deCampos (2017) conducted a randomized clinical
trial to identify the frequency of change of chlorhexidine-impregnated gel dressings
applied in central venous catheter insertions sites in critically ill patients. Fifty two
patients above 18 years of age with the short-term central venous catheter and using
chlorhexidine-impregnated gel dressing in a high complexity intensive care unit in a
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teaching hospital in the state of São Paulo in Brazil were eligible for the study. Thirteen
nurses of the ICU participated in the training and data collection. The nurses who
participated in the study completed training and practice on application and removal of
the dressing using a mannequin with a CVC. A sterile gauze fixed with adhesive tape as a
dressing was used during the first 24 hours after the CVC insertion until the local
bleeding has seized. The chlorhexidine-impregnated gel dressings followed and changed
after seven days or as needed. Data were collected on a daily basis between April and
December 2014. The researchers assessed the dressing and when the dressing had been
changed and verified the reason for the change. A total of 64 catheters were analyzed
with a total of 159 dressings used with a mean frequency of change being 3.04 days (SD
= 1.917). A total of 95 changes occurred among the 159 utilized dressings. Among the 64
CVCs, 25 were applied in a single dressing, without replacement of the dressing, and in
39 catheters there was no need to apply a new dressing after removal of the last one.
Considering the interruption of use of the catheter by the patients, 87% (83) dressings
were unscheduled due to detachment and were from CVC in the subclavian vein, and
13% (12) were scheduled changes. The study concluded that the frequency of dressing
changes was less than seven days, resulting in more significant quantities of dressings per
patient caused by the detachment of the dressings (Dolci et al., 2017).
Karpanen et al., (2016) conducted a prospective comparative non-blinded singlecenter clinical study to determine the antimicrobial efficacy of CHG (CHG) gel dressing
used in patients with a CVC. Two hundred and seventy three adults above 18 years of age
who required a CVC as part of their clinical management admitted to critical care unit in
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a large university hospital with 75 critical care beds divided into four units between
January 2013 and October 2014. One hundred and thirty seven patients were randomized
to standard dressing (3M Tegaderm™ IV dressing containing no antimicrobial) group
and 136 patients in chlorhexidine dressing (an adhesive, semipermeable, transparent
polyurethane film dressing incorporating a transparent gel pad containing 2% CHG)
group. The non-antimicrobial standard dressing study phases were divided into two study
periods, before and after the CHG dressing phase. The standard dressing was the part of
routine dressing for the CVC care in the hospital before the study. The first phase
included recruiting half of the standard dressing group patients, and then the CHG
introduced. After the CHG phase, the standard dressing was reintroduced and studied.
The study revealed a significant reduction in the number of microorganisms recovered
from the CHG gel pad when implemented with standard CVC site care compared to the
standard dressing (Karpanen et al., 2016).
Biehl and colleagues (2016) conducted an open-label, randomized, multicenter
trial to investigate the effects of CVC dressings with CHG-containing gel pads in the
setting of high-risk neutropenic patients. This was the first known randomized trial to
evaluate a transparent CVC dressing with a chlorhexidine gel pad in neutropenic patients.
The trial was done in 10 German hematological departments comparing the safety and
efficacy of chlorhexidine-containing gel pad transparent CVC dressing with an advanced
transparent CVC dressing without antimicrobial gel pad between February 2012 and
September 2014. A total of 613 patients met the inclusion criteria to participate in the ten
study sites. 307 patients were randomized to the CHG group (n= 307) and 306 patients to
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the Control group (n= 306). The study revealed that the application of chlorhexidine
containing catheter securement dressings reduces the incidence of definite or probable
central line related bloodstream infections in neutropenic patients. The infections dropped
overall from 17.3% to 10.4% (p= 0.014) and within 14 days of CVC placement from
11.15 to 6.5% (p= 0.047) (Biehl et al., 2016).
Olson and Heilman (2008) conducted a single-center randomized controlled trial
to evaluate a new CHG catheter dressing, 3M Tegaderm™ CHG IV Securement Dressing
for its practicality of use in clinical practice on central venous access devices compared to
the non-CHG Tegaderm™ dressing. Sixty three patients between the age of 28-88
admitted in Allina Hospitals requiring a central venous catheter with a peripherally
inserted central catheter, intrajugular central venous catheter, subclavian venous catheter,
or femoral venous catheter and expected to remain in place for at least three days were
included in the study. Thirty three patients were randomized to the CHG dressing group
and 30 in the control group. The clinicians assessed the dressing based on the catheter
securement, satisfaction with the dressing, ability to see the insertion site, ease of
applying a dressing and the ease of using the dressing correctly, dressing adherence, skin
stripping, maceration, erythema, and edema. The study revealed that the new 3M
Tegaderm™ CHG gel dressing was as easy to use as the standard of care (nonantimicrobial transparent adhesive dressing) and offered many advantages over standard
dressing such as antimicrobial activities, handles moderate bleeding and remains
transparent and appear to provide greater catheter securement than the standard dressing
and conformed well to the catheter (Olson & Heilman, 2008).
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Eyberg and Pyrek (2008) conducted a controlled randomized prospective
comparative pilot study to evaluate the ease of use and easier of training of application
between a transparent CHG dressing versus a CHG disk (Biopatch®) in healthy
volunteers. Twelve healthy intravascular therapy health care professionals above age 18
years specializing in vascular access and infusion therapy with experience in applying
and changing IV dressings in their practice were involved in the evaluation. The
clinicians had not used the CHG gel before but had used the CHG disk in their practice.
Dressings were applied randomly to the subjects’ locations in the right and the left side of
the neck and left and right arms and the subjects were asked to remove them. A total of
24 CHG gel dressing and 24 CHG gel disks were applied. The study concluded that the
CHG gel dressing was significantly better in overall performance (p<0.0001) compared
to the CHG disk. All the 12 clinicians rated the CHG gel dressing better or much better,
easier to apply, ease of removing, ability to see the IV site, ease of training another
clinician to use, and more intuitive to use compared to the CHG disk (Eyberg & Pyrek,
2008).
Bashir, Olson, and Waters (2012) conducted a randomized controlled trial to
compare the performance of the antimicrobial polyurethane film dressing to two CHGcontaining insertion site dressings concerning the abilities of the CHG-containing
dressings to suppress bacterial regrowth over a seven days’ time frame in the healthy
adult. Thirty-two healthy male and female above 18 years of age with no dermatological
conditions participated in the study. At the beginning of the study, four baselines samples
of normal flora were collected from each subject. Two samples on the upper back and
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two on the lower back. The subjects’ skin was prepped with a 2% CHG/70% isopropyl
alcohol antiseptic. The three dressings (Tegaderm™ transparent films dressing, CHG gel
and CHG disk) were placed on the prepped skin in a randomized design. Samples of
bacteria were collected using the cup scrub method. The skin under the dressings was
sampled by quadrant on days 1, 4, and 7. The suppression of the regrowth of bacteria was
compared using an adjusted paired t-test. The study revealed that skin flora was not
wholly eradicated during antisepsis, and regrowth occurred post antisepsis. The use of
CHG gel dressings helped sustain a reduced bacterial count on the skin, and the
continuously releasing CHG gel maintained suppression to a greater extent that the CHG
disk at seven days (P = .01) (Bashir et al., 2012).
Maki et al. (2008) conducted a prospective comparative randomized controlled
trial to compare two novel CHG-impregnated dressings (CHG Tegaderm™ gel and
sponge) in healthy volunteers to assess the immediate and long-term surface cutaneous
antimicrobial activity of the two CHG (Tegaderm™ CHG gel and Biopatch®) dressings
and a control non-medicated transparent dressing in healthy subjects. 48 healthy adults
aged between 25 to 70 years without primary skin disorder or known allergy to CHG
participated in the regrowth study on prepped subclavian sites at a Hilltop Research in
Miami Ville in Ohio and 29 subjects participated in the trial assessing killing of normal
flora on unprepped skin in research conducted in the Medical Division Laboratory of 3M
Company in St. Paul Minnesota. The study was conducted by evaluating the
antimicrobial activity of the two CHG dressing against normal cutaneous microflora on
the back of the subjects by measuring the flora counts under the dressings after 1,2,4,7
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and 10 days on sites that were not prepped with an antiseptic at the outset. Each of the
two test areas, one on the right and other on the left were randomly sampled for sample
counts on day zero. The 2 CHG dressings were randomly applied to the two remaining
sites. By random assignment, one of each test CHG dressings was removed from each
side on study days 1, 2, 4, 7, and 10 and quantitative skin cultures were obtained. The
study concluded that the newly integrated CHG gel dressing showed powerful
bactericidal activity against diverse nosocomial species, and both CHG dressings studied
showed excellent immediate and especially, long-term cutaneous floral suppression and
were tolerated. The new integrated transparent CHG impregnated gel dressing is easier to
apply and less vulnerable to improper application, reliably secures the catheter, permits
continuous inspection of the insertion site, and obviates the need for every-other-day site
care (Maki et al., 2008).
Rupp et al., (2008) conducted a prospective, randomized controlled single-center
clinical trial in a 689 bed at Nebraska Medical Center, a University-associated, tertiary
care center to assess the clinical performance of an innovative CHG Tegaderm™
dressing containing CHG gel pad in minimizing the growth of microbes at the catheter
insertion site. 60 adults’ patients with the central venous catheter that was likely to
remain in place at least three days participated in the study. Tegaderm™ CHG containing
gel dressing and the transparent, semipermeable polyurethane dressings were randomly
assigned to the insertion site. Dressings were evaluated daily for adherence, catheter
securement, transparency, and skin condition, the presence of moisture or blood, and
patient comfort. At day seven, the microbiologic assessment was done for subjects with
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catheters seven days of continuous study dressing wear by collecting a swab culture at the
catheter insertion site. The study revealed that the Tegaderm™ CHG dressing containing
a chlorhexidine gel pad is an innovate means to minimize catheter-associated
bloodstream infection potentially. The Tegaderm™ CHG dressing is well-tolerated and
judged to be superior to the comparator dressing with regard to catheter securement and
overall satisfaction (Rupp et al., 2008).
Level 3 of Evidence
Level 3 in the hierarchy of evidence is the evidence obtained from well-designed
controlled trials without randomization (Melynk et al., 2011). Zehrer, Smith, and
Deschneau (2010) conducted a multicenter clinical trial to compare the performance of a
new transparent CHG gel pad dressing versus a CHG disk (plus transparent dressing). A
total of 321 clinicians from 16 US hospitals were enrolled to evaluate the application of
500 new CHG gel pad dressings. The 16 hospitals were using the CHG disk (Biopatch®)
before the clinical evaluation. During the time of the study, the nurses only applied the
new CHG gel dressing and completed a written questionnaire after the study to compare
the two products. 80.6% (95% lower CI: 76.2%) of evaluators recommended replacing
their current product with the transparent CHG gel pad dressing (p=0.0178) (Zehrer et al.,
2010).
Pfaff, Heithaus, and Emanuelsen (2012) conducted a quality improvement
observation study in an adult medical-surgical intensive care unit in a 20 beds critical
care unit in at Staten Island University Hospital in New York in 2009. The objective was
to compare the effectiveness of the use of a new 1-piece CHG transparent gel dressing
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with a chlorhexidine patch (Biopatch®) in maintaining the low rate of catheter-related
bloodstream infections in the intensive care unit and to evaluate nurses’ satisfaction with
and cost of the new dressing. All patients who were admitted in the critical care unit
requiring central catheters had a CHG gel pad dressing applied. Sixty-two nurses
participated in placing the CHG gel dressing, and 30 responded to the survey. The study
revealed that eliminating the Biopatch®, the new CHG gel dressing will have cost saving
of $3.42 per dressing change. During the study period of 1881 device days, the infection
rate dropped from 0.052 per 1000 device days in 2008 to 0.0051 per 1000 days in 2009.
Nurses preferred the new dressing compared to the old dressing, and the new dressing
had a total cost savings of $3807. Therefore, the new dressing can lead to a lower rate of
catheter-related bloodstream infections, increase nurses’ satisfaction, and contribute to
cost savings (Pfaff et al., 2012).
Karpanen et al., (2015) conducted a clinical trial to evaluate the introduction,
performance, and clinical staff perceptions of the standard transparent intravenous
dressing in comparison to the transparent film intravenous line dressing with a CHG gel
pad at the insertion site of short-term central venous catheters and vascular access
catheters for dialysis in adult critical care patients. The evaluation involved 273 patients
in 75 critical care beds in a University Hospital at the city of Birmingham in the UK.
CHG dressing, (n= 136) and Standard dressing (n= 137). 71 nurses and ten clinicians
responded to the survey. The staffs were trained and were competent to handle central
venous catheter per the hospital policy. Questionnaires were used as a form of evaluation
after 12 months of the use of standard transparent dressing (dressing used in throughout
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the hospital) and after nine months use of the IV dressing incorporating a CHG gel pad.
The anonymous questionnaires that were returned in sealed boxes after completion was
directly distributed to the trained nurses in the critical care and anesthetist in the
operating theaters who had experience with CVC insertion and competency. The majority
of the clinical staff (70 out of 81 respondents) considered the performance of the IV
dressing containing a CHG gel pad better or much better than the standard dressing.
Seventy seven out of 78 respondents recommended continuing its use. Both types of
dressing performed better well when applied to the insertion site of IV catheters in the
internal jugular, subclavian, and femoral care patients (Karpanen et al., 2015).
Guclu et al., (2014) conducted a before (SP-1) and after clinical trial (SP-2) to
investigate the efficacy of chlorhexidine-impregnated gel dressings in reducing the
catheter-related bloodstream infections (CRBSI). The study was conducted between
January 2010 and December 2011 in a six-bed intensive care unit of a tertiary care
hospital involving 991 adult patients (521 patients in sterile dry gauze before the study
and 470 in chlorhexidine-impregnated gel dressings after the study). In the first trial part
of the study (between January 2010 and December 2010), sterile gauze was used as a
catheter side dressing and changed every two days unless the dressing became saturated
or loosened and in the second part of the study period (January 2011 and December
2011), 2% chlorhexidine-impregnated gel dressings (Tegaderm™ 3M) were used and
changed every seven days unless needed to be changed before the time. The infection
control nurse and the infectious disease specialist evaluated patients for hospital-acquired
infections every morning. Ninety four central venous catheters were inserted for the first
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study (823 catheter days) and 53 central venous catheters were inserted for the second
part of the study (560 catheter days). Six and five central-line related bloodstream
infections were observed in SP-1 and SP-2 respectively (p>0.05). The study concluded
that although there were decreased numbers of CVC inserted on the SP-2, the incidences
of CRBSIs between the two periods did not differ (p>0.05) (Guclu et al., 2014).
Moureau, Deschneau, and Pyrek (2009) conducted a clinical evaluation to
statistically validate the performance of a new CHG gel dressing in the clinical setting by
skilled IV nurses and to compare the new CHG gel dressing to the CHG disk in six
United States hospitals from different states. Sixty four IV nurse’s evaluators participated
in the clinical evaluation with a total of 500 new CHG gel dressings applied during the
evaluation period for 73 days. Study sites were selected based on their current use of a
CHG antimicrobial absorptive foam disk (CHG disk/Biopatch®). Nurses’ evaluators used
an integrated transparent absorbent CHG gel dressing in place of their current CHG disk
plus transparent dressing. Each site participated for a period of minimum 14 days, and the
nurse evaluators completed the questionnaires at the end of the evaluation period. The
evaluation questions were in 16 levels striated into four performance groups: ease of
application, gel dressing performance, securement function and other. The new CHG gel
dressing was rated significantly better than the comparative CHG disk plus transparent
dressing in overall performance (p<0.0001); 90.5% of evaluators rated the new dressing
as equal to or better than, the comparative dressing. The new CHG gel dressings were
evaluated significantly better in all dimensions of performance studied. The study
concluded that the CHG gel dressing provides antimicrobial activity at the insertion site

61
in an integrated dressing that is easy to use and has a higher level of clinical performance
and less chance for application error that would lead to better compliance to established
standards of practice (Moureau et al., (2009).
Evidence Synthesis
Reduction of CLABSIs. Different studies demonstrated the efficacy of CHG
Tegaderm™ gel in the reduction of CLABIs. A meta-analysis of randomized control
trials study by Safdar and colleagues (2014) reviewed that the use of chlorhexidineimpregnated dressing results in the reduction of the prevalence of CLABSI. Similarly,
multiple randomized controlled trials conducted by Timsit et al., (2012) indicated that the
use of CHG Tegaderm™ gel results in significant reduction of CLABSI counting to 57%
reduction of the patient with infections and 60% reduction of infection per 1000 catheter
days while using the CHG gel dressing. In a prospective randomized clinical trial done by
Karpanen and colleagues (2016) to evaluate the antimicrobial efficacy of the CHG gel in
patients with CVC, the study revealed a significant reduction of the number of
microorganisms recovered from CHG gel compared to the standard dressing. In a study
done by Biehl et al., (2016) to evaluate the efficacy of CHG gel in neutropenic patients
with CVC, the randomized multicenter trials revealed that the application of CHG gel
dressing reduces the CRBSI indefinitely. Pedrolo and colleagues (2014) in their
randomized clinical trial to assess the effectiveness of the chlorhexidine antimicrobial
dressing in comparison to the gauze and tape dressing revealed no significant differences
between the two dressing regarding the occurrence of CLABSIs, local reactions to the
dressing and dressing fixation. Bashir et al., (2012) in their randomized clinical trial study
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to compare the CHG gel with CHG Biopatch® (disk) revealed that the use of CHG gel is
essential in the reduction of CLABSI because of the ability to maintain suppression of
regrowth of bacteria after antisepsis during the central line insertion because the CHG gel
ensures continuous releasing of CHG. Rupp and colleagues (2008) in their prospective
randomized single-center controlled trial to assess the clinical performance of innovative
CHG Tegaderm™ dressing containing CHG gel pad in minimizing the growth of the
microbes at the catheter insertion site revealed that the use of CHG gel helps to mitigate
the CLABSI. The Mourea et al., (2009) in their non-randomized clinical trial to evaluate
the clinical performance of the CHG gel revealed that the dressing provides antimicrobial
activity at the insertion site compared to the CHG disk. Maki and colleagues (2008) in
their comparative analysis between CHG Tegaderm™ gel and CHG Biopatch® in a nonrandomized clinical trial revered that the CHG gel dressing provides superior prevention
of floral regrowth on prepped sites and progressive kill of the cutaneous microflora on
unprepped sites compared to the CHG sponges (Biopatch®).
Cost-effectiveness. To assess the cost-effectiveness of the CHG gel, different
studies were identified that yield the benefit of how economical the CHG gel is in the
cost reduction. In the meta-analysis study done by Mauoury et al., 2015) using
multicenter randomized controlled trials, the CHG gel is considered more cost-effective
than the standard antimicrobial dressing because of the ability to reduce the numbers of
CLABSI hence reduce the cost associated with CLABSIs. Heiman and colleagues (2012)
in their clinical controlled trial to evaluate the health economic analysis on the use of
CHG gel compared to non-CHG dressings revealed that although the overall direct costs
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of using both dressings are the same, the CHG dressing provides better antimicrobial
coverage that leads to lower rate of probable CLABSIs that will lead to decreased costs.
Pfaff et al., 2012 in their quasi-experimental studies to compare the effectiveness of CHG
gel compared to the CHG Biopatch® revealed that the use of CHG gel is cost-effective in
the reduction or elimination of CLABSIs compared to the CHG Biopatch®.
Easiness of use, application, view of the insertion site, and staff satisfaction.
The use of CHG gel is supported with evidence on the easiness of use, easiness of
application, easier to view the insertion site and staff satisfaction on its use. For instance,
Olson and colleagues in their randomized control trial to evaluate the new CHG gel
Tegaderm™ dressing for its practicality of use in clinical practice on central venous
devices revealed that the dressing is easy to use in central venous catheter care as the
standard dressing and it offers more advantages compared to the standard nonantimicrobial dressing. In their study to evaluate the ease of use of a transparent CHG gel
dressing versus the CHG disk (Biopatch®), Eyberg and colleagues (2008) using a
randomized prospective comparative study revealed that the CHG gel dressing is better
compared to the Biopatch® in regard to its ease of application, ease of applying correctly,
ease of removal, ability to visualize the insertion site, and ease of training others on how
to use the CHG gel dressing as a one-step dressing compared to the use of CHG disk
together with transparent dressing as a two-step dressings. Rupp et al., 2008 in their
randomized controlled trials to assess the clinical performance of CHG gel dressing
concluded that the CHG gel dressing is well-tolerated well by the patients with a central
venous catheter, has better securement and clinicians judge the dressing as more superior
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and more satisfaction of using it compared to the CHG Biopatch®. Karpanen et al., 2015,
in their clinical trial to evaluate the performance of the CHG gel dressing in clinical
environment revealed that the CHG gel is well tolerated and patients whose dressing
were applied performed excellently in the critical care environment. By evaluating the
clinical performance of the CHG gel transparent dressing, Mourea et al., 2009 in the
experimental study concluded that the CHG gel has a more significant clinical
performance and less chance for application error that would lead to better compliance to
established standards of practice compared with CHG disk. Maki et al., 2008 in their
prospective comparative clinical study revealed that the use of CHG gel dressing is more
superior and advantage to using compared to the CHG Biopatch® in that it is easier to
apply, secures the catheter and permits continuous inspection of the insertion site because
it is transparent compared to the Biopatch® which is opaque. Zehrer and colleagues
(2010) in their clinical trial to of clinicians evaluating the performance of CHG gel to the
CHG disk (Biopatch®) revealed that clinicians recommended the CHG gel pad dressing
over the CHG disk due to ease of use and ability to visualize the IV site. Pfaff and
colleagues (2012) in their experimental study to compare the effectiveness of the CHG
gel dressing with Biopatch® concluded that the nurses who used the CHG gel were more
satisfied and preferred using the dressing than using the CHG Biopatch®.
Impacts on the Findings
The primary goal of this systematic review was to find whether there is enough
substantial evidence that can support the intervention of using an adhesive transparent
CHG gel in the prevention of central-line associated bloodstream infections (CLABISs).
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Based on the above findings, this systematic review has answered the clinical question or
practice-focused question formulated before the start of this systematic review because
they indicated that the adhesive transparent CHG Tegaderm™ gel dressing for the central
venous catheter is superior compared to the chlorhexidine Biopatch® in decreasing the
central-line associated bloodstream infections.
The review of the meta-analysis of the randomized controlled trials, and
randomized controlled trials, and the non-randomized clinical trials yielded enough
evidence to support the use of CHG Tegaderm™ gel in place of Biopatch® for the
central venous catheter. Unlike the Biopatch® that require two steps dressing (Biopatch®
film/disk covered with transparent adhesive dressing) the CHG Tegaderm™ gel dressing
is a one-way dressing that incorporates the gel and the dressing, and it makes it easier to
apply and to use. Unlike the Biopatch® that is opaque and makes it difficult to view the
insertion site, the use of CHG Tegaderm™ gel makes it easier to see the insertion site and
makes it easy to monitor in case of any signs of infection.
The articles reviewed indicated that the use of CHG will be economical because it
can decrease the rates of CLABSIs that result to cost burden to the patients, facility, and
the health care at large. Different studies such as meta-analysis of multiple randomized
trials conducted by Safdar and colleagues (2014) found that the CDC gel has a high
prevalence of reducing the CLABSIs. Numerous randomized clinical trials such as Timsit
and colleagues (2012), Karpanen and Colleagues (2016), Biehl and Colleagues (2016),
Pfaff and colleagues (2012), Eyberge and colleagues (2008), Rupp et al., (2008), and
Bashir and Colleagues (2012) found that the use of CHG gel is significant in the
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reduction of CLABSIs compared to the standard antimicrobial transparent dressing,
gauze or chlorhexidine disk (Biopatch®). Also, different clinical trials such as Moureau
et al., (2009) found that the use of CHG gel dressing provides antimicrobial activity at the
insertion site in an integrated dressing that is easy to use. The CHG gel has a more
significant clinical performance and less chance for application error that would lead to
better compliance with established standards of practice compared to the CHG disk
(Biopatch®).
Clinical trials such as Heimann et al., (2018) found that although the use of CHG
gel dressings is expensive, the expenses are outweighing by a lower rate of
probable/definite CLABSIs and reduced associated costs. Karpanen et al., 2015 while
evaluating the clinical performance of chlorhexidine gel containing dressing in clinical
environment found that the CHG gel CVC dressing was well tolerated by patients and
performed excellently in the critical care environment. Other studies such as a clinical
trial conducted by Zehler et al., (2010), Olson et al., (2008) to evaluate the performance
of using CHG gel revealed that clinicians recommended the CHG gel pad dressing over
the CHG disk due to ease of use, ability to visualize the IV site, and the ability to absorb
fluid.
The cost impact of using the CHG gel was also evaluated and multiple studies
such as the meta-analysis conducted by Maunoury and colleagues (2015) revealed a
significant decrease in the number of CLABSI using CHG gel that led to the lower cost
of patients’ care associated by CLABSIs and CLABSIs related conditions. The study by
Pfaff et al., (2012) revealed that the use of CHG gel was cost-effective compared to the
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chlorhexidine Biopatch® and it reduces or eliminates the incidence of catheter-related
bloodstream infections and nurses preferred using the dressing gel compared to the
chlorhexidine Biopatch®.
Therefore, the included studies in this systematic review discussed the impact of
chlorhexidine on the reduction of CLABSIs, its cost-effectiveness, the easiness of its use,
the ability to continually assess the site of insertion, and the ease to teach others to apply
the CHG gel. The dressing is widely recommendations by nurses who have previously
used the CHG disk (Biopatch®) to switch to CHG gel as the dressing is user-friendly and
more economical.
Implications for Social Change
The purpose of conducting this systematic review was to gather, analyze and
synthesize evidence that will lead to decrease in the numbers of CLABSIs for acute or
critically ill patients that cause mortality, morbidity, and cost burden to the patients,
facility and the health care at large. Through the evidence obtained, there is clear
understanding that implementing the findings of the systematic review and adopting the
use of CHG Tegaderm gel dressing and other central line care, the number of CLABSIs
will decrease compared to the use of CHG Biopatch®. The use of CHG Tegaderm gel
dressing has proven to not only prevents the rates of CLABSI but it is cost effective
compared to other dressings due to the ability to avoid CLABSIs that can cause huge cost
burden to the patients’, facility and the health care. By decreasing the rates of CLABSIs,
the chances of mortality and morbidity that can eliminate the productive members of the
society are reduced and therefore, it is not only contributing to improve health care, but it
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is also contributing to the economic aspect of a nation or humankind. The use of this
systematic review will have a social implication in the local facility if implemented
because of the already struggling need to reduce the number of CLABSIs despite the
adherence to the CDC 2011 central line care bundles. By implementing this systematic
review, the local facility can reach their target of reducing the number of CLABSIs from
the current rate hence save health care dollars and lives.
Recommendations
The products of this systematic review provide a clear evidence that can be
implemented as a quality improvement project in the care of central venous catheter in a
facility that is struggling in the reduction of the central-line related bloodstream
infections. The recommendations are after careful analysis and synthesis of the
researched articles that proved that the proposed treatment modality (adhesive transparent
CHG Tegaderm gel dressing) is superior to the use of CHG Biopatch® covered with an
adhesive transparent dressing. The use of adhesive transparent CHG gel dressing is useful
when implemented with other central venous catheter care bundles as indicated by the
CDC 2011 guidelines. The CHG gel dressing provides a clear view of the insertion site
that is important to monitor when patients have the central venous catheter. For the CHG
gel dressing to yield results compared to the CHG disk, the usual care and central venous
standard bundles should be followed as outlined earlier in this study. For the intervention
to be implemented the management and the leadership should look at the different
strategies of how to provide clear teaching and enough practices to the end users on how
to apply for the intervention to be deemed sufficient to achieve the targeted results of
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reducing the CLABSIs. After implementation, the facility should compare one year
before the implementation and one year after the implementation regarding cost for the
dressing, nurses’ evaluation on the usefulness and performance of the dressing and the
rate of CLABSIs compared with the previous standard dressing used.
Strengths of the Findings
The study included larger numbers of randomized controlled trials, clinical
control trials, and two meta-analyses and excluded levels 4-7 of the Melynk's et al.,
(2011) hierarchy of evidence. Levels 1 and 2 articles are considered the highest level
evidence, and few articles are level 3 that are clinical trials. The advantages of using level
1 and 2 are that they have fewer risks of bias because the patients have equal chances to
be in the intervention and control group due to randomization. Therefore, having multiple
studies that included either one or multiple randomized controlled trials are clear
evidence that the intervention is well supported and had been studied and proved to work
through clinical trials. By use of this systematic review, the local facility and the nursing
practice can use the study as the guide of evidence and have confidence that changing the
chlorhexidine Biopatch® to chlorhexidine gel in addition to the standard central line
bundles care can lead to decrease or lead to zero numbers of CLABSIs. Lowering the
numbers of CLABSIs will save the health care costs and reduce mortality and morbidity
associated with CLABSIs or CLABSIs-related illnesses.
Limitations on Findings
There is no systematic review found that met criteria for inclusion in this
systematic review and only two meta-analyses of the randomized controlled trials that
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were available were included in the study. Only studies that were in the English language
were included in the study. Studies that were in foreign language and could have
contributed to this systematic review were excluded due to lack of translator or inability
to translate. Also, only online published literature was used as a source of evidence for
the study. Probably some articles in the paper format could have contributed to the study,
but they were excluded. Articles that were not clear or not discussing the chlorhexidine
gel dressing were excluded to reduce bias. Articles with a level of evidence 4-7 according
to the Melynk et al., (2011) were excluded from the studies. The selected number of full
articles that qualified for the review outnumbered the non-supportive articles, and
therefore, the impact of non-supportive articles was little on the systematic review. The
study only included one reviewer that was involved in the whole process of the
systematic review such as retrieving, reviewing and selecting articles unlike the
traditional method of more than one reviewer in the systematic review and this could
create bias.
My aim of conducting this systematic literature review was to find, retrieve,
analyze and synthesize the best available evidence to support the use of CHG gel dressing
in the reduction of central-line associated bloodstream infections in adults in acute or
critical care units. In this section 4, I identified the method of articles selection, the
number of articles selected and those that met the inclusion criteria. I also summarized
the articles identified and discussed the strength and limitations of the study discussed.
Also, the recommendation for the study was included. Based on the findings, the
intervention proposed is well supported by the evidence from the meta-analysis,
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randomized controlled trials, and non-randomized clinical trials. Based on the results of
this study, there is enough confidence that the management and nursing leadership at the
local facility can use these findings as the basis for changing the current use of
Biopatch® covered by adhesive transparent dressing to a dressing that integrates the
CHG gel to the adhesive transparent dressing. The findings provide enough evidence that
it reduces the rate of CLABSIs, is cost-effective, is rated high as more effective, easy to
use, easy to apply and remove and easy to teach others on the use of CHG gel as it is a
one-step dressing compared to the two steps in the CHG Biopatch®.
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Section 5: Dissemination Plan
The gap on the best method to prevent the CLABSIs in patients with central
venous catheter admitted to the acute and critical care units remains. The purpose of this
systematic review was to find, retrieve, analyze and synthesize the best available
evidence from the current published literature that will support the use of adhesive
transparent CHG gel dressings in the prevention of CLABSIs. The systematic review was
guided by the logic model that acted as a blueprint by steering in the formulation of the
practice-focused question, set the inclusion criteria, conduct in the retrieval of evidence,
summarize them and make the conclusion of whether the evidence answered the practicefocused question to achieve the desired outcomes.
The results of this systematic review indicated that there is clear evidence that the
use of the proposed treatment modality, if implemented besides other central line care
bundles, will drastically reduce the rate of CLABSIs. It will also lead to a decrease in the
highest cost that the facilities bare when a CLABSI is diagnosed as it is considered a nonreimbursed nosocomial infection. Not only does it reduce the unnecessary costs to the
facility but will also reduce the health care cost burden and save lives. This review will
be provided to the local facility nursing leadership for evaluation and dissemination. The
review will include the background information, evidence from literature, the summary
of the evidence and the recommendations. The information in this review will be
presented through a power point presentation, handouts or printouts to the appropriate
management and leadership and the nursing services. The implementation of the
proposed treatment intervention will be recommended so that the organization can
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receive the benefits and the goal target of reducing the CLABSIs rate. Due to the highest
level of evidence obtained and having clinical trials and randomized clinical trials
conducted in different settings both nationally and internationally, the potential for other
health care organizations to use the data from this systematic review could also provide
insights and benefits in the reduction or bring to probable zero the deadly hospitalacquired disease called CLABSI. Also, further research or systematic review and metaanalysis on the application of CHG gel dressing could bear more fruits in future.
Audiences and Venues Appropriate for Dissemination
My purpose of conducting this integrative review was to search and retrieve an
extensive literature to support a treatment modality that is considered superior in the
prevention of CALBSIs in acute and critical care units. Due to the needs of daily use of
the CVC for medications, food, fluid or hemodynamic monitoring, the risk of patients
developing CLABSI increases. As a dressing that is not widely being used, proper
audiences to disseminate and present the findings of the systematic review will be local
acute and critical care units and other nursing organizations such as the American
Association of Critical Care nurses and doctors, as well as the American Nurses
Association during their conferences.
Analysis of Self
My journey through the DNP program at Walden University began in May 2017
as a continuation of my Master of Science in nursing to achieve my lifetime dream goals.
The journey has not been easy, but with the aspiration, hardworking, perseverance and
determination I can testify that everything is possible once you set your eyes on it. During
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the process of conducting this systematic review, my knowledge on how to turn research
into evidence has been harnessed. My hopes for the future are to be a significant
contributor in the field of nursing as a scholar and a mentor to others going through the
process of the doctoral studies. As a previous staff nurse in the critical care unit, I have
taken care of patients diagnosed with CLABSI despite the meticulous application of the
2011 CDC guidelines in the care of central venous catheter, and some led to mortality or
increased hospital stay, and this broke my heart. Therefore, having a project that is
tailored to the prevention and decrease of the rate of CLABSIs is both personally and
professionally fulfilling. As a doctoral prepared nurse, the hallmark of the doctoral
education is demonstrating the ability to critically appraise available literature and
evidence and implement it as an evidence-based practice. I articulated that by conducting
this extensive integrative literature review, I have mastered the American Association of
Colleges of Nursing DNP Essential III: Clinical Scholarship and Analytical Methods for
Evidence-based Practice (American Association of Colleges of Nursing, 2006).
As a doctoral-prepared nurse, I will be at the forefront to use the skills attained
during my doctoral studies. By conducting this systematic review, the findings will be
used to support facilities and nursing practice in the quality improvement programs to
improve patients’ outcomes. As a result of conducting this doctoral project, I have
harnessed my knowledge and ability in searching and retrieving evidence from literature
and analyzing the evidence to solve simple and complex clinical problems. Moreover, my
professional goals have been tailored to be a scholar, mentor, and educator. I will use my
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knowledge and experience gained during this doctoral journey to improve nursing
practice and my professional growth.
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Summary
CLABSI is an infection that occurs within 48 hours of central line placement.
CLABSIs are considered the costliest HAIs. CLABSIs are preventable if the right care
and measures are taken. The CDC has CVC care guidelines, but the guidelines are not
rigid on the dressing to be used during the CVC care. Traditionally, the CHG Biopatch®
covered with adhesive transparent dressing has been used as CLABSI prevention
measures together with the CDC guidelines. In spite of facilities adhering to the CDC
guidelines in addition to the use of Biopatch® covered with an Adhesive transparent
dressing, the rate of CLABSI continues to rise.
In Section 1 of this doctoral review, I discussed the nature of the project by
identifying the project question, the nature of the study, and the importance of the
proposed treatment modality. In this case, the purpose of this systematic review was to
conduct an integrative review of the literature on the use of adhesive transparent CHG
Tegaderm™ dressing in the prevention of CLABSI. The dressing is a new one method
dressing which is composed of an adhesive transparent Tegaderm™ with CHG gel that
releases the CHG continuously and allows the view of the insertion site, unlike the
Biopatch® which is opaque and requires the disk to be covered by an adhesive
transparent dressing making it a two way process. A predefined PICOT question was
formulated that guided the review as well as the inclusion and exclusion criteria.
In Section 2, I discussed the background the context of the doctoral project. A
framework that guided this systematic review was logic model, which is considered as a
roadmap and guided the whole systematic review from identifying the inclusions criteria

77
to retrieving the evidence and determine the outcomes from the findings if implemented.
The role of the project in the nursing practice was discussed and how the student as a
project manager contributed from the start to finish of the review. The reason why the
project is carried due to the needs at the local facility was discussed and how the findings
will impact the care and improve patients’ outcome locally and in nursing practice.
In Section 3, the review discusses how the evidence was collected and
synthesized. The review discusses the steps to conduct the retrieval of evidence by first
contacting the university review board, and after the approval as a preapproved for DNP
project; the student conducted an extensive data search. Different databases such as the
Cochrane, PUBMED, EMBASE, CINAHL, MEDLINE, ProQuest Nursing, and Google
Scholar were used to find and retrieve the published literature to support the hypothesis
of the predefined practice question. By thoroughly and extensively searching the above
databases and google scholar, 373 articles were retrieved and assessed fully to identify
the articles that met the criteria based on the predefined inclusion criteria. A total of 16
articles qualified for the final review by meeting the criteria and 11 full articles assessed
did not meet the criteria. The articles that met the criteria were graded using the Melynk
and Fineout-Overholt hierarchy level of evidence.
In Section 4, I discussed the findings and the recommendation of the systematic
review of the literature. I broke down the evidence synthesis into how effective the CHG
gel Tegaderm™ is effective in the reduction of CLABSI, how economical is the CHG gel
Tegaderm™ and how easier it is to use the CHG gel Tegaderm™ compared to the
Biopatch® with an adhesive transparent dressing. Based on the findings of the literature
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review, the use of CHG gel dressing is core in the fight to reduce the rate of the deadly
CLABSIs. Due to the strength of findings from meta-analysis and single and multiple
randomized controlled trials, the use of CHG Tegaderm™ gel is well supported by the
literature as an effective method of controlling CLABSI, reducing health care burdens
and reducing mortality and morbidity associated with CLABSI or CLABSI-related
illnesses.
In Section 5, I discussed the dissemination plan. I explained the appropriate
audiences that will benefit from the findings of the review such as the local acute care
critical care units, National nursing associations such as the American Association of
Critical care Nurses and the American Nurses Association.
In conclusion, the process of conducting this review has been personally and
professionally fulfilling. The doctoral program and the process of conducting this
systematic review have helped me to improve on how to turn research into practice in
solving complex nursing issues and how to improve patients’ outcomes. It is my plan to
continue building my professional journey as a mentor, teacher, scholar, and practitioner.
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